닫기
Search
Advanced Search +
닫기
Quick links
최근 원고 원고 검색 많이 읽은 원고 온라인 논문 투고

Erratum

Split Viewer

Public Health Weekly Report 2024; 17(12): 471-471

Published online March 28, 2024

https://doi.org/10.56786/PHWR.2024.17.12.3

© The Korea Disease Control and Prevention Agency

저자 오류 보고: 제17권 제10호

This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Go to

https://doi.org/10.56786/PHWR.2024.17.10.2

Public Health Wkly Rep 2024;17(10):404-417

주간 건강과 질병 제17권 제10호의 ‘[조사/감시 보고] 국내 A형간염 개별 사례의 특성 및 집단발생 양상 파악, 2019-2022년’ 논문 저자의 성명이 개명됨에 따라 다음과 같이 수정합니다.

1. 저자명(p.404)

김하연, 채승훈, 양진선*

2. Author name (p.411)

Ha Yeon Kim, Seung-Hoon Chae, Jin Seon Yang*

3. Author Contributions (p.410, 417)

Conceptualization: HYK, SHC, JSY. Data curation: HYK. Formal analysis: HYK. Methodology: HYK, SHC. Project administration: HYK SHC, JSY. Supervision: JSY, SHC. Visualization: HYK. Writing – original draft: HYK. Writing – review & editing: HYK, SHC, JSY.

References

Go to
  1. Alman BL, Stingone JA, Yazdy M, et al. Associations between PM2.5 and risk of preterm birth among liveborn infants. Ann Epidemiol 2019;39:46-53.e2.
    Pubmed KoreaMed CrossRef
  2. Arroyo V, Díaz J, Carmona R, Ortiz C, Linares C. Impact of air pollution and temperature on adverse birth outcomes: Madrid, 2001-2009. Environ Pollut 2016;218:1154-61.
    Pubmed CrossRef
  3. Arroyo V, Díaz J, Ortiz C, Carmona R, Sáez M, Linares C. Short term effect of air pollution, noise and heat waves on preterm births in Madrid (Spain). Environ Res 2016;145:162-8.
    Pubmed CrossRef
  4. Avalos LA, Chen H, Li DK, Basu R. The impact of high apparent temperature on spontaneous preterm delivery: a case-crossover study. Environ Health 2017;16:5.
    Pubmed KoreaMed CrossRef
  5. Basagaña X, Michael Y, Lensky IM, et al. Low and high ambient temperatures during pregnancy and birth weight among 624,940 singleton term births in Israel (2010-2014): an investigation of potential windows of susceptibility. Environ Health Perspect 2021;129:107001.
    Pubmed KoreaMed CrossRef
  6. Basu R, Rau R, Pearson D, Malig B. Temperature and term low birth weight in California. Am J Epidemiol 2018;187:2306-14.
    Pubmed CrossRef
  7. Bekkar B, Pacheco S, Basu R, DeNicola N. Association of air pollution and heat exposure with preterm birth, low birth weight, and stillbirth in the US: a systematic review. JAMA Netw Open 2020;3:e208243. Erratum in: JAMA Netw Open 2020;3:e2014510.
    Pubmed KoreaMed CrossRef
  8. Bernstein AS, Sun S, Weinberger KR, Spangler KR, Sheffield PE, Wellenius GA. Warm season and emergency department visits to U.S. children's hospitals. Environ Health Perspect 2022;130:17001. Erratum in: Environ Health Perspect 2022;130:49002.
    Pubmed KoreaMed CrossRef
  9. Bhaskaran K, Gasparrini A, Hajat S, Smeeth L, Armstrong B. Time series regression studies in environmental epidemiology. Int J Epidemiol 2013;42:1187-95.
    Pubmed KoreaMed CrossRef
  10. World Health Organization (WHO). Global action plan for the prevention and control of noncommunicable diseases 2013-2020. WHO; 2013.
  11. Ministry of Health and WelfareKorea Health Promotion Institute. The 5th national health plan (health plan 2030, 2021~2030). Korea Health Promotion Institute 2022; Rev. ed.
  12. Kim YT, Choi BY, Lee KO, et al. Overview of Korean community health survey. J Korean Med Assoc 2012;55:74-83.
    CrossRef
  13. World Health Organization (WHO). Noncommunicable diseases [Internet]. WHO; 2023 [cited 2023 Oct 30].
    Available from: https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases
  14. Jekal Y, Lee MK, Kim ES, et al. Effects of walking and physical activity on glucose regulation among type 2 diabetics. Korean Diabetes J 2008;32:60-7.
    CrossRef
  15. Imkampe AK, Gulliford MC. Increasing socio-economic inequality in type 2 diabetes prevalence--repeated cross-sectional surveys in England 1994-2006. Eur J Public Health 2011;21:484-90.
    Pubmed CrossRef
  16. Jung CH, Son JW, Kang S, et al. Diabetes fact sheets in Korea, 2020: an appraisal of current status. Diabetes Metab J 2021;45:1-10.
    Pubmed KoreaMed CrossRef
  17. Lee MS, Lee KS, Lee JJ, et al. Directions and current issues on the policy of prevention and management for hypertension and diabetes, and development of chronic disease prevention and management model in Korea. J Agric Med Community Health 2020;45:13-40.
  18. The 2007 Recommendations of the International Commission on Radiological Protection. ICRP publication 103. Ann ICRP 2007;37:1-332.
    Pubmed CrossRef
  19. Medical service act, Act No.17787, Enforcement Date 2021 Jun 30. Article 37 [Internet]. Korea Legislation Research Institute; 2020 [cited 2022 Sep 23].
    Available from: https://elaw.klri.re.kr/kor_service/lawView.do?hseq=60889&lang=ENG
  20. Korea Disease Control and Prevention Agency. 2019 Report occupational radiation exposure in diagnostic radiology in Korea. Korea Disease Control and Prevention Agency; 2020.
  21. Korea Disease Control and Prevention Agency. 2020 Report occupational radiation exposure in diagnostic radiology in Korea. Korea Disease Control and Prevention Agency; 2021.
  22. Korea Disease Control and Prevention Agency. 2021 Report occupational radiation exposure in diagnostic radiology in Korea. Korea Disease Control and Prevention Agency; 2022.
  23. Korea Disease Control and Prevention Agency. Korea health statistics 2021: Korea National Health and Nutrition Examination Survey (KNHANES VIII-3). Korea Disease Control and Prevention Agency; 2022.
  24. Haslam DW, James WP. Obesity. Lancet 2005;366:1197-209.
    Pubmed CrossRef
  25. Mayasari NR, Hu TY, Chao JC, et al. Associations of the pre-pregnancy weight status with anaemia and the erythropoiesis-related micronutrient status. Public Health Nutr 2021;24:6247-57.
    Pubmed CrossRef
  26. Ng KYB, Cherian G, Kermack AJ, et al. Systematic review and meta-analysis of female lifestyle factors and risk of recurrent pregnancy loss. Sci Rep 2021;11:7081.
    Pubmed KoreaMed CrossRef
  27. Park J, Han S, Jang HD, Shin G, Han K, Hong JY. Underweight as a risk factor for vertebral fractures in the South Korean population. Spine J 2023;23:877-84.
    Pubmed CrossRef
  28. Korean Society for the Study of Obesity. Quick reference guideline. Korean Society for the Study of Obesity; 2020.
  29. Ministry of Health and Welfare. Dietary reference intakes for Koreans. Ministry of Health and Welfare; 2015.
    CrossRef
  30. Cho YG. Why does weight gain put more stress on women?. Korean J Fam Med 2020;41:363-4.
    Pubmed KoreaMed CrossRef
  31. Kim D. Body image distortion and appearance management behaviors in women and their policy implications. Health Welf Policy Forum 2021;299:40-58.
  32. Park SY. Gender statistics. Body type polarization among Korean women: obese or underweight (2023).
  33. Noh JW, Kwon YD, Yang Y, Cheon J, Kim J. Relationship between body image and weight status in east Asian countries: comparison between South Korea and Taiwan. BMC Public Health 2018;18:814.
    Pubmed KoreaMed CrossRef
  34. Park B, Cho HN, Choi E, et al. Self-perceptions of body weight status according to age-groups among Korean women: a nationwide population-based survey. PLoS One 2019;14:e0210486.
    Pubmed KoreaMed CrossRef
  35. Park B, Cho HN, Choi E, et al. Weight control behaviors according to body weight status and accuracy of weight perceptions among Korean women: a nationwide population-based survey. Sci Rep 2019;9:9127.
    Pubmed KoreaMed CrossRef
  36. Montani JP, Schutz Y, Dulloo AG. Dieting and weight cycling as risk factors for cardiometabolic diseases: who is really at risk?. Obes Rev 2015;16 Suppl 1:7-18.
    Pubmed CrossRef
  37. Martin CB, Herrick KA, Sarafrazi N, Ogden CL. Attempts to lose weight among adults in the United States, 2013-2016. NCHS Data Brief 2018;(313):1-8.
    Pubmed
  38. Klos LA, Sobal J. Marital status and body weight, weight perception, and weight management among U.S. adults. Eat Behav 2013;14:500-7.
    Pubmed CrossRef
  39. Siu J, Giskes K, Turrell G. Socio-economic differences in weight-control behaviours and barriers to weight control. Public Health Nutr 2011;14:1768-78.
    Pubmed CrossRef
  40. Peralta RL, Barr PB. Gender orientation and alcohol-related weight control behavior among male and female college students. J Am Coll Health 2017;65:229-42.
    Pubmed CrossRef
  41. Kim JH. Associations between weight control behavior and health behaviors in Korean young women: 2013 Community Health Survey. J Korea Acad Ind Coop Soc 2015;16:4734-44.
    CrossRef
  42. Oh YS, Cho YG. Exploring the limitations in the use of online health information and future direction: focused on analysis of expert knowledge in the frame of ignorance. Health Soc Welf Rev 2019;39:358-93.
    CrossRef
  43. Choi SK, Kim HY, Hwang JN, et al. A study for improving health literacy. Korea Institute for Health and Social Affairs; 2020.
  44. Syed-Abdul S, Fernandez-Luque L, Jian WS, et al. Misleading health-related information promoted through video-based social media: anorexia on YouTube. J Med Internet Res 2013;15:e30.
    Pubmed KoreaMed CrossRef
  45. Choi SK, Chun HR, Choi EJ. Review of recent digital health literacy programs in Europe and the United States. Korean J Health Educ Promot 2022;39:15-28.
    CrossRef
  46. Sørensen K, Van den Broucke S, Fullam J, et al. Health literacy and public health: a systematic review and integration of definitions and models. BMC Public Health 2012;12:80.
    Pubmed KoreaMed CrossRef
  47. Korea Institute for Health and Social Affairs. Korea Disease Control and Prevention Agency; 2023 [cited 2023 Jul 10].
    Available from: https://health.kdca.go.kr/
  48. Johnson JD, Case DO. Health information seeking. Peter Lang; 2012.
    CrossRef
  49. Korea Health Promotion Institute. The 5th National Health Plan (Health Plan 2030, 2021~2030). Seoul: Korea Health Promotion Institute; 2022 Apr. Report No.: 정책- 04-2022-008-01. 139 p.
  50. National Health Service. National Health Service. Content policy [Internet]. National Health Service; 2022 [cited 2023 Sep 8]. Available from: www.nhs.uk/our-policies/content-policy/
  51. Korea Disease Control and Prevention Agency Press Release. 2023 [cited 2023 Sep 8].
    Available from: https://www.kdca.go.kr/board/board.es?mid=a20501010000&bid=0015&act=view&list_no=722564
  52. Alman BL, Stingone JA, Yazdy M, et al. Associations between PM2.5 and risk of preterm birth among liveborn infants. Ann Epidemiol 2019;39:46-53.e2.
    Pubmed KoreaMed CrossRef
  53. Arroyo V, Díaz J, Carmona R, Ortiz C, Linares C. Impact of air pollution and temperature on adverse birth outcomes: Madrid, 2001-2009. Environ Pollut 2016;218:1154-61.
    Pubmed CrossRef
  54. Arroyo V, Díaz J, Ortiz C, Carmona R, Sáez M, Linares C. Short term effect of air pollution, noise and heat waves on preterm births in Madrid (Spain). Environ Res 2016;145:162-8.
    Pubmed CrossRef
  55. Avalos LA, Chen H, Li DK, Basu R. The impact of high apparent temperature on spontaneous preterm delivery: a case-crossover study. Environ Health 2017;16:5.
    Pubmed KoreaMed CrossRef
  56. Basagaña X, Michael Y, Lensky IM, et al. Low and high ambient temperatures during pregnancy and birth weight among 624,940 singleton term births in Israel (2010-2014): an investigation of potential windows of susceptibility. Environ Health Perspect 2021;129:107001.
    Pubmed KoreaMed CrossRef
  57. Basu R, Rau R, Pearson D, Malig B. Temperature and term low birth weight in California. Am J Epidemiol 2018;187:2306-14.
    Pubmed CrossRef
  58. Bekkar B, Pacheco S, Basu R, DeNicola N. Association of air pollution and heat exposure with preterm birth, low birth weight, and stillbirth in the US: a systematic review. JAMA Netw Open 2020;3:e208243. Erratum in: JAMA Netw Open 2020;3:e2014510.
    Pubmed KoreaMed CrossRef
  59. Bernstein AS, Sun S, Weinberger KR, Spangler KR, Sheffield PE, Wellenius GA. Warm season and emergency department visits to U.S. children's hospitals. Environ Health Perspect 2022;130:17001. Erratum in: Environ Health Perspect 2022;130:49002.
    Pubmed KoreaMed CrossRef
  60. Bhaskaran K, Gasparrini A, Hajat S, Smeeth L, Armstrong B. Time series regression studies in environmental epidemiology. Int J Epidemiol 2013;42:1187-95.
    Pubmed KoreaMed CrossRef
  61. World Health Organization (WHO). Global action plan for the prevention and control of noncommunicable diseases 2013-2020. WHO; 2013.
  62. Ministry of Health and WelfareKorea Health Promotion Institute. The 5th national health plan (health plan 2030, 2021~2030). Korea Health Promotion Institute 2022; Rev. ed.
  63. Kim YT, Choi BY, Lee KO, et al. Overview of Korean community health survey. J Korean Med Assoc 2012;55:74-83.
    CrossRef
  64. World Health Organization (WHO). Noncommunicable diseases [Internet]. WHO; 2023 [cited 2023 Oct 30].
    Available from: https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases
  65. Jekal Y, Lee MK, Kim ES, et al. Effects of walking and physical activity on glucose regulation among type 2 diabetics. Korean Diabetes J 2008;32:60-7.
    CrossRef
  66. Imkampe AK, Gulliford MC. Increasing socio-economic inequality in type 2 diabetes prevalence--repeated cross-sectional surveys in England 1994-2006. Eur J Public Health 2011;21:484-90.
    Pubmed CrossRef
  67. Jung CH, Son JW, Kang S, et al. Diabetes fact sheets in Korea, 2020: an appraisal of current status. Diabetes Metab J 2021;45:1-10.
    Pubmed KoreaMed CrossRef
  68. Lee MS, Lee KS, Lee JJ, et al. Directions and current issues on the policy of prevention and management for hypertension and diabetes, and development of chronic disease prevention and management model in Korea. J Agric Med Community Health 2020;45:13-40.
  69. The 2007 Recommendations of the International Commission on Radiological Protection. ICRP publication 103. Ann ICRP 2007;37:1-332.
    Pubmed CrossRef
  70. Medical service act, Act No.17787, Enforcement Date 2021 Jun 30. Article 37 [Internet]. Korea Legislation Research Institute; 2020 [cited 2022 Sep 23].
    Available from: https://elaw.klri.re.kr/kor_service/lawView.do?hseq=60889&lang=ENG
  71. Korea Disease Control and Prevention Agency. 2019 Report occupational radiation exposure in diagnostic radiology in Korea. Korea Disease Control and Prevention Agency; 2020.
  72. Korea Disease Control and Prevention Agency. 2020 Report occupational radiation exposure in diagnostic radiology in Korea. Korea Disease Control and Prevention Agency; 2021.
  73. Korea Disease Control and Prevention Agency. 2021 Report occupational radiation exposure in diagnostic radiology in Korea. Korea Disease Control and Prevention Agency; 2022.
  74. WHO coronavirus (COVID-19) dashboard [Internet]. World Health Organization; 2023 [cited 2023 Jun 26].
    Available from: http://covid19.who.int/table
  75. World Health Organization. Multi-country outbreak of mpox, External Situation Report 19. World Health Organization; 2023.
  76. Korea Centers for Disease Control and Prevention. Middle East respiratory syndrome coronavirus outbreak in the Republic of Korea, 2015. Osong Public Health Res Perspect 2015;6:269-78. Erratum in: Osong Public Health Res Perspect 2016;7:138.
    Pubmed KoreaMed CrossRef
  77. Inglesby TV, O’Toole T, Henderson DA, et al. Anthrax as a biological weapon, 2002: updated recommendations for management. JAMA 2002;287:2236-52. Erratum in: JAMA 2002;288:1849.
    Pubmed CrossRef
  78. Riedel S. Plague: from natural disease to bioterrorism. Proc (Bayl Univ Med Cent) 2005;18:116-24.
    Pubmed KoreaMed CrossRef
  79. Korea Disease Control and Prevention Agency (KDCA). Guideline for gene recombinantion experiment. KDCA; 2023.
  80. Korea Disease Control and Prevention Agency (KDCA). Institutional Biosafety Committee organization & operating guide. KDCA; 2021.
  81. Whitmore A. An account of a glanders-like disease occurring in Rangoon. J Hyg (Lond) 1913;13:1-34.
    Pubmed KoreaMed CrossRef
  82. Kaestli M, Mayo M, Harrington G, et al. Landscape changes influence the occurrence of the melioidosis bacterium Burkholderia pseudomallei in soil in northern Australia. PLoS Negl Trop Dis 2009;3:e364.
    Pubmed KoreaMed CrossRef
  83. Currie BJ, Mayo M, Anstey NM, Donohoe P, Haase A, Kemp DJ. A cluster of melioidosis cases from an endemic region is clonal and is linked to the water supply using molecular typing of Burkholderia pseudomallei isolates. Am J Trop Med Hyg 2001;65:177-9.
    CrossRef
  84. Chen PS, Chen YS, Lin HH, et al. Airborne transmission of melioidosis to humans from environmental aerosols contaminated with B. pseudomallei. PLoS Negl Trop Dis 2015;9:e0003834.
    Pubmed KoreaMed CrossRef
  85. Currie BJ, Ward L, Cheng AC. The epidemiology and clinical spectrum of melioidosis: 540 cases from the 20 year Darwin prospective study. PLoS Negl Trop Dis 2010;4:e900.
    Pubmed KoreaMed CrossRef
  86. Deris ZZ, Hasan H, Siti Suraiya MN. Clinical characteristics and outcomes of bacteraemic melioidosis in a teaching hospital in a northeastern state of Malaysia: a five-year review. J Infect Dev Ctries 2010;4:430-5.
    CrossRef
  87. 2021 Multistate outbreak of melioidosis [Internet]. Centers for Disease Control and Prevention; 2021 [cited 2021 Nov 4].
    Available from: https://www.cdc.gov/melioidosis/outbreak/2021/index.html
  88. Limmathurotsakul D, Wongratanacheewin S, Teerawattanasook N, et al. Increasing incidence of human melioidosis in Northeast Thailand. Am J Trop Med Hyg 2010;82:1113-7.
    Pubmed KoreaMed CrossRef
  89. Currie BJ, Jacups SP, Cheng AC, et al. Melioidosis epidemiology and risk factors from a prospective whole-population study in northern Australia. Trop Med Int Health 2004;9:1167-74.
    Pubmed CrossRef
  90. Fong SM, Wong KJ, Fukushima M, Yeo TW. Thalassemia major is a major risk factor for pediatric melioidosis in Kota Kinabalu, Sabah, Malaysia. Clin Infect Dis 2015;60:1802-7.
    CrossRef
  91. Cheng AC, Currie BJ. Melioidosis: epidemiology, pathophysiology, and management. Clin Microbiol Rev 2005;18:383-416. Erratum in: Clin Microbiol Rev 2007;20:533.
    Pubmed KoreaMed CrossRef
  92. Wiersinga WJ, Virk HS, Torres AG, et al. Melioidosis. Nat Rev Dis Primers 2018;4:17107.
    Pubmed KoreaMed CrossRef
  93. Thomas RJ. Particle size and pathogenicity in the respiratory tract. Virulence 2013;4:847-58.
    Pubmed KoreaMed CrossRef
  94. Tan GG, Liu Y, Sivalingam SP, et al. Burkholderia pseudomallei aerosol infection results in differential inflammatory responses in BALB/c and C57Bl/6 mice. J Med Microbiol 2008;57(Pt 4):508-15.
    Pubmed CrossRef
  95. Sun GW, Gan YH. Unraveling type III secretion systems in the highly versatile Burkholderia pseudomallei. Trends Microbiol 2010;18:561-8.
    Pubmed CrossRef
  96. David J, Bell RE, Clark GC. Mechanisms of disease: host-pathogen interactions between Burkholderia species and lung epithelial cells. Front Cell Infect Microbiol 2015;5:80.
    Pubmed KoreaMed CrossRef
  97. Lazar Adler NR, Govan B, Cullinane M, Harper M, Adler B, Boyce JD. The molecular and cellular basis of pathogenesis in melioidosis: how does Burkholderia pseudomallei cause disease?. FEMS Microbiol Rev 2009;33:1079-99.
    Pubmed CrossRef
  98. Nathan SA, Puthucheary SD. An electronmicroscopic study of the interaction of Burkholderia pseudomallei and human macrophages. Malays J Pathol 2005;27:3-7.
    Pubmed
  99. Ceballos-Olvera I, Sahoo M, Miller MA, Del Barrio L, Re F. Inflammasome-dependent pyroptosis and IL-18 protect against Burkholderia pseudomallei lung infection while IL-1β is deleterious. PLoS Pathog 2011;7:e1002452.
    Pubmed KoreaMed CrossRef
  100. French CT, Toesca IJ, Wu TH, et al. Dissection of the Burkholderia intracellular life cycle using a photothermal nanoblade. Proc Natl Acad Sci U S A 2011;108:12095-100.
    Pubmed KoreaMed CrossRef
  101. Newland RC. Chronic melioidosis: a case in Sydney. Pathology 1969;1:149-52.
    Pubmed CrossRef
  102. Gee JE, Gulvik CA, Elrod MG, et al. Phylogeography of Burkholderia pseudomallei isolates, Western Hemisphere. Emerg Infect Dis 2017;23:1133-8.
    Pubmed KoreaMed CrossRef
  103. Ngauy V, Lemeshev Y, Sadkowski L, Crawford G. Cutaneous melioidosis in a man who was taken as a prisoner of war by the Japanese during World War II. J Clin Microbiol 2005;43:970-2.
    CrossRef
  104. Vadivelu J, Vellasamy KM, Thimma J, et al. Survival and intra-nuclear trafficking of Burkholderia pseudomallei: strategies of evasion from immune surveillance?. PLoS Negl Trop Dis 2017;11:e0005241.
    Pubmed KoreaMed CrossRef
  105. Welkos SL, Klimko CP, Kern SJ, et al. Characterization of Burkholderia pseudomallei strains using a murine intraperitoneal infection model and in vitro macrophage assays. PLoS One 2015;10:e0124667.
    Pubmed KoreaMed CrossRef
  106. Limmathurotsakul D, Golding N, Dance DA, et al. Predicted global distribution of Burkholderia pseudomallei and burden of melioidosis. Nat Microbiol 2016;1:15008.
    Pubmed KoreaMed CrossRef
  107. Garg R, Shaw T, Vandana KE, Magazine R, Mukhopadhyay C. Melioidosis in suspected recurrent tuberculosis: a disease in disguise. J Infect Dev Ctries 2020;14:312-6.
    Pubmed CrossRef
  108. Hoffmaster AR, AuCoin D, Baccam P, et al. Melioidosis diagnostic workshop, 2013. Emerg Infect Dis 2015;21:e141045.
    Pubmed KoreaMed CrossRef
  109. Puthucheary SD. Melioidosis in Malaysia. Med J Malaysia 2009;64:266-74.
    Pubmed CrossRef
  110. Currie BJ. Melioidosis: evolving concepts in epidemiology, pathogenesis, and treatment. Semin Respir Crit Care Med 2015;36:111-25.
    Pubmed CrossRef
  111. Woods DE. Species versus biotype status. J Clin Microbiol 1999;37:3786-7.
    Pubmed KoreaMed CrossRef
  112. Podin Y, Kaestli M, McMahon N, et al. Reliability of automated biochemical identification of Burkholderia pseudomallei is regionally dependent. J Clin Microbiol 2013;51:3076-8.
    Pubmed KoreaMed CrossRef
  113. Schully KL, Young CC, Mayo M, et al. Next-generation diagnostics for melioidosis: evaluation of a prototype i-STAT cartridge to detect Burkholderia pseudomallei biomarkers. Clin Infect Dis 2019;69:421-7.
    Pubmed CrossRef
  114. Wuthiekanun V, Desakorn V, Wongsuvan G, et al. Rapid immunofluorescence microscopy for diagnosis of melioidosis. Clin Diagn Lab Immunol 2005;12:555-6.
    Pubmed KoreaMed CrossRef
  115. Phokrai P, Karoonboonyanan W, Thanapattarapairoj N, et al. A rapid immunochromatography test based on Hcp1 is a potential point-of-care test for serological diagnosis of melioidosis. J Clin Microbiol 2018;56:e00346-18.
    Pubmed KoreaMed CrossRef
  116. Lau SK, idhar S Sr, Ho CC, et al. Laboratory diagnosis of melioidosis: past, present and future. Exp Biol Med (Maywood) 2015;240:742-51.
    Pubmed KoreaMed CrossRef
  117. Chantratita N, Meumann E, Thanwisai A, et al. Loop-mediated isothermal amplification method targeting the TTS1 gene cluster for detection of Burkholderia pseudomallei and diagnosis of melioidosis. J Clin Microbiol 2008;46:568-73.
    Pubmed KoreaMed CrossRef
  118. Fairley L, Smith S, Maisrikrod S, Henning L. Systematic review and meta-analysis of diagnostic tests for diagnosis of melioidosis. Acta Trop 2021;214:105784.
    Pubmed CrossRef
  119. Wong Tzeling JM, Engku Nur Syafirah EAR, Irekeola AA, et al. One-step, multiplex, dual-function oligonucleotide of loop-mediated isothermal amplification assay for the detection of pathogenic Burkholderia pseudomallei. Anal Chim Acta 2021;1171:338682.
    Pubmed CrossRef
  120. Limmathurotsakul D, Kanoksil M, Wuthiekanun V, et al. Activities of daily living associated with acquisition of melioidosis in northeast Thailand: a matched case-control study. PLoS Negl Trop Dis 2013;7:e2072.
    Pubmed KoreaMed CrossRef
  121. Crowe A, McMahon N, Currie BJ, Baird RW. Current antimicrobial susceptibility of first-episode melioidosis Burkholderia pseudomallei isolates from the Northern Territory, Australia. Int J Antimicrob Agents 2014;44:160-2.
    Pubmed CrossRef
  122. Dance DA, Davong V, Soeng S, Phetsouvanh R, Newton PN, Turner P. Trimethoprim/sulfamethoxazole resistance in Burkholderia pseudomallei. Int J Antimicrob Agents 2014;44:368-9.
    Pubmed KoreaMed CrossRef
  123. Rhodes KA, Schweizer HP. Antibiotic resistance in Burkholderia species. Drug Resist Updat 2016;28:82-90.
    Pubmed KoreaMed CrossRef
  124. Podin Y, Sarovich DS, Price EP, et al. Burkholderia pseudomallei isolates from Sarawak, Malaysian Borneo, are predominantly susceptible to aminoglycosides and macrolides. Antimicrob Agents Chemother 2014;58:162-6.
    Pubmed KoreaMed CrossRef
  125. Chetchotisakd P, Chierakul W, Chaowagul W, et al. Trimethoprim-sulfamethoxazole versus trimethoprim-sulfamethoxazole plus doxycycline as oral eradicative treatment for melioidosis (MERTH): a multicentre, double-blind, non-inferiority, randomised controlled trial. Lancet 2014;383:807-14.
    Pubmed KoreaMed CrossRef
  126. White NJ, Dance DA, Chaowagul W, Wattanagoon Y, Wuthiekanun V, Pitakwatchara N. Halving of mortality of severe melioidosis by ceftazidime. Lancet 1989;2:697-701.
    Pubmed CrossRef
  127. Smith MD, Wuthiekanun V, Walsh AL, White NJ. In-vitro activity of carbapenem antibiotics against beta-lactam susceptible and resistant strains of Burkholderia pseudomallei. J Antimicrob Chemother 1996;37:611-5.
    Pubmed CrossRef
  128. Cheng AC, McBryde ES, Wuthiekanun V, et al. Dosing regimens of cotrimoxazole (trimethoprim-sulfamethoxazole) for melioidosis. Antimicrob Agents Chemother 2009;53:4193-9.
    Pubmed KoreaMed CrossRef
  129. Rare Disease Helpline [Internet]. Korea Disease Control and Prevention Agency; 2018 [cited 2020 Apr 13].
    Available from: https://helpline.kdca.go.kr/cdchelp/
  130. Korea Disease Control and Prevention Agency. National fundholding system for rare disease. Korea Disease Control and Prevention Agency; 2022.
  131. Codjoe FS, Donkor ES. Carbapenem resistance: a review. Med Sci (Basel) 2017;6:1.
    Pubmed KoreaMed CrossRef
  132. Korea Disease Control and Prevention Agency (KDCA). 2023 Guidelines for control of healthcare-associated infection. KDCA; 2023.
  133. Joo S, Kim M, Shin E, Kim J, Yoo J. Molecular characteristic analysis and antimicrobial resistance of carbapenem-resistant Enterobacteriaceae (CRE) isolates in the Republic of Korea, 2017-2020. Public Health Wkly Rep 2021;14:3790-804.
  134. Kim MK, Joo S, Shin E, Kim J, Yoo J. Antimicrobial resistance and molecular characteristics of carbapenem-resistant Enterobacteriaceae isolated in the Republic of Korea, 2021. Public Health Wkly Rep 2023;16:541-59.
  135. Yun SJ, Kwon SM, Hur ES, et al. Outbreaks of carbapenem resistant Enterobacterales (CRE) according to the type of hospitals. Korean J healthc assoc Infect Control Prev 2022;27:162-7.
    CrossRef
  136. Centers for Disease Control and Prevention (CDC). Carbapenem-resistant Enterobacterales (CRE) [Internet]. CDC; 2019 [cited 2023 Sep 1].
    Available from: https://www.cdc.gov/hai/organisms/cre/index.html
  137. Korea Disease Control and Prevention Agency (KDCA). Annual report on the notified infectious diseases in Korea, 2022. KDCA; 2023.
  138. Ahn YS, Bahk HJ, Lee Y. Epidemiology of carbapenem-resistant Enterobacteriaceae in Korea between 2018 and 2019. Public Health Wkly Rep 2021;14:413-20.
  139. Lee E, Lee S, Yoon S, Lee Y. Number of cabapenem-resistant Enterobacteriaceae infections in Republic of Korea (2018-2020). Public Health Wkly Rep 2021;14:2765-72.
  140. Jeong H, Hyun J, Lee Y. Characteristics of carbapenem-resistant Enterobacteriaceae (CRE) in the Republic of Korea, 2021. Public Health Wkly Rep 2022;15:2354-63.
  141. Centers for Disease Control and Prevention (2023). National Notifiable Diseases Surveillance System, Weekly Tables of Infectious Disease Data [Internet].
    Available from: https://wonder.cdc.gov/nndss/static/2023/04/2023-04-table355.html. (cited 2023 Sep 1)
  142. Quarterly laboratory surveillance of acquired carbapenemase-producing Gram-negative bacteria in England: October 2020 to September 2022. Health Prot Rep 2023;17:1-29. Health Prot Rep 2023;17:1-29.
  143. Centers for Disease Control and Prevention (CDC). Interim guidance for a public health response to contain novel or targeted multidrug-resistant organisms (MDROs). CDC; 2022.
  144. Korea Disease Control and Prevention Agency Press Release [cited 2023 Apr 12]
    Available from: https://www.kdca.go.kr/board/board.es?mid=a20501010000&bid=0015&list_no=722274&cg_code=&act=view&nPage=3
  145. Holmes EC, Goldstein SA, Rasmussen AL, et al. The origins of SARS-CoV-2: a critical review. Cell 2021;184:4848-56.
    Pubmed KoreaMed CrossRef
  146. Hinshaw D, McKay B. WHO seeks to revive stalled inquiry into origins of Covid-19 with new team [Internet]. Wall Street Journal; 2021 [cited 2023 Oct 26].
    Available from: https://www.wsj.com/articles/who-seeks-to-revive-stalled-inquiry-into-origins-of-covid-19-with-new-team-11632657603
  147. Cairney P, Heikkila T, Wood M. Making policy in a complex world. Cambridge University Press; 2019.
    CrossRef
  148. Shiffman J, Shawar YR. Framing and the formation of global health priorities. Lancet 2022;399:1977-90.
    Pubmed CrossRef
  149. Cairney P, Fischer M, Ingold K. Fracking in the UK and Switzerland: why differences in policymaking systems don't always produce different outputs and outcomes. Policy Polit 2018;46:125-47.
  150. World Health Organization. COVID 19 strategic preparedness and response plan - monitoring and evaluation framework. World Health Organization; 2021.
    CrossRef
  151. Korea Disease Control and Prevention AgencyNational Academy of Medicine of Korea. Analysis of the Central Disease Control Headquarters' COVID-19 pandemic response from 2020 to 2021 [Internet]. Korea Disease Control and Prevention Agency; 2023 [cited 2023 Nov 12].
    Available from: https://prism.go.kr/homepage/entire/researchDetail.do?researchId=1790387-202200048&menuNo=I0000002
  152. On the 12th, the Korea Centers for Disease Control and Prevention will be promoted to the Korea Disease Control and Prevention Agency | COVID-19 Central Disaster and Safety Countermeasures Headquarters Briefing (September 8, 2020) [Internet]. KTV; 2020 [cited 2023 Nov 8].
    Available from: https://www.youtube.com/watch?v=N0AEgvQ65Mc
  153. Haug N, Geyrhofer L, Londei A, et al. Ranking the effectiveness of worldwide COVID-19 government interventions. Nat Hum Behav 2020;4:1303-12.
    Pubmed CrossRef
  154. WHO warns of 'two-track pandemic' as cases decline but vaccine inequity persists [Internet]. United Nations; 2021 [cited 2023 Nov 14].
    Available from: https://news.un.org/en/story/2021/06/1093472
  155. Geddes L. Different types of immunity and why they matter to COVID-19 [Internet]. VaccinesWork; 2020 [cited 2023 Nov 1].
    Available from: https://www.gavi.org/vaccineswork/different-types-immunity-and-why-they-matter-covid-19?gclid=Cj0KCQjwy4KqBhD0ARIsAEbCt6jMkvzlFcbF4VV7rDqvZlGyWo_NL_em1n7lQUudfSiUSRBN3d_Y40saAnilEALw_wcB
  156. Ando H, Ikegami K, Nagata T, et al. Effect of commuting on the risk of COVID-19 and COVID-19-induced anxiety in Japan, December 2020. Arch Public Health 2021;79:222.
    Pubmed KoreaMed CrossRef
  157. Weir L. Inventing global health security, 1994-2005. In: Rushton S, Youde J, editors. Routledge handbook of global health security. London: Routledge 2014:p.18-31.
    CrossRef
  158. Tarrow S. Power in movement: social movements and contentious politics. 2nd ed. Cambridge University Press. 1998.
    CrossRef
  159. Grant W. Pressure groups, politics and democracy in Britain. 2nd ed. Harvester Wheatsheaf. 1995.
    CrossRef
  160. Snowden FM. Epidemics and society: from the Black Death to the present. Yale University Press; 2019.
    CrossRef
  161. Korea Disease Control and Prevention Agency. Guidelines for water- and foodborne disease. Korea Disease Control and Prevention Agency; 2023. p. 3-5, 43-44.
  162. World Health Organization. Foodborne disease outbreaks: guidelines for investigation and control. World Health Organization; 2008.
    CrossRef
  163. Lee J, Seo S, Noh Y, Kim H, Lee D. Results of the water- and foodborne disease surveillance during the summer of 2021. Public Health Wkly Rep 2021;14:3320-8.
  164. Kim DS, Kim I, Kim H, Shim JA, Won J, Gwak J. Results of the food and waterborne disease surveillance during the summer in 2022. Public Health Wkly Rep 2023;16:36-50.
  165. Rose JB, Epstein PR, Lipp EK, Sherman BH, Bernard SM, Patz JA. Climate variability and change in the United States: potential impacts on water- and foodborne diseases caused by microbiologic agents. Environ Health Perspect 2001;109(Suppl 2):211-21.
    Pubmed KoreaMed CrossRef
  166. Gwack J, Lee KC, Lee HJ, et al. Trends in water- and foodborne disease outbreaks in Korea, 2007-2009. Osong Public Health Res Perspect 2010;1:50-4.
    Pubmed KoreaMed CrossRef
  167. Lee SH, Yun JW, Lee JH, Jung YH, Lee DH. Trends in recent waterborne and foodborne disease outbreaks in South Korea, 2015-2019. Osong Public Health Res Perspect 2021;12:73-9.
    Pubmed KoreaMed CrossRef
  168. Korea Meteorological Administration. Climate analysis Information Monthly Newsletter - October. Korea Meteorological Administration; 2023.
  169. Shin HS, Chung KH, Yun SM, Lee S. Climate change, food-borne disease prediction, and future impact. Health Soc Welf Rev 2009;29:143-62.
    CrossRef
  170. Ministry of Food and Drug Safety. Guidelines for food safety management. Ministry of Food and Drug Safety; 2022.
  171. Liu X, He Y, Tang C, et al. Association between cold spells and childhood asthma in Hefei, an analysis based on different definitions and characteristics. Environ Res 2021;195:110738.
    Pubmed CrossRef
  172. Korea Meteorological Administration. Abnormal climate report, 2022. Korea Meteorological Administration; 2023.
  173. Lane K, Ito K, Johnson S, Gibson EA, Tang A, Matte T. Burden and risk factors for cold-related illness and death in New York City. Int J Environ Res Public Health 2018;15:632.
    Pubmed KoreaMed CrossRef
  174. Analitis A, Katsouyanni K, Biggeri A, et al. Effects of cold weather on mortality: results from 15 European cities within the PHEWE project. Am J Epidemiol 2008;168:1397-408.
    Pubmed CrossRef
  175. Korea Disease Control and Prevention Agency. The 1st climate health impact assessment report. Korea Disease Control and Prevention Agency; 2022.
    CrossRef
  176. Korea Disease Control and Prevention Agency. 2023 Guidelines for healthcare-associated infectious diseases. Korea Disease Control and Prevention Agency; 2023.
    CrossRef
  177. Tischendorf J, de Avila RA, Safdar N. Risk of infection following colonization with carbapenem-resistant Enterobactericeae: a systematic review. Am J Infect Control 2016;44:539-43.
    Pubmed KoreaMed CrossRef
  178. Lee ES, Lee SJ, Yoon SJ, Lee Y. Number of Cabapenem-resistant Enterobacteriaceae infections in Republic of Korea (2018-2020). Public Health Wkly Rep 2021;14:2765-72.
  179. Jeong HS, Hyun JH, Lee YK. Characteristics of Carbapenem-resistant Enterobacteriaceae (CRE) in the Republic of Korea, 2021. Public Health Wkly Rep 2022;15:2354-63.
  180. Public Health Agency of Canada. Tackling antimicrobial resistance and antimicrobial use: a pan-Canadian framework for action. Public Health Agency of Canada; 2017.
  181. Australian Commission on Safety and Quality in Health Care. AURA 2021: fourth Australian report on antimicrobial use and resistance in human health. Australian Commission on Safety and Quality in Health Care; 2021. p. fourth.
  182. Bijkerk P, Feenstra SG, Notermans DW, Schouls LM, Wielders CCH, Leenstra T. [Notification requirement for carbapenemase-producing Enterobacteriaceae]. Infect Bull 2020;31. Dutch.
    Available from: https://www.rivm.nl/weblog/meldingsplicht-voor-carbapenemaseproducerende-enterobacteriaceae-ib-09-2020
  183. Federal Government. DART 2020: fighting antibiotic resistance for the good of both humans and animals. Federal Government; 2015. p. fighting.
    CrossRef
  184. Federal Task Force on Combating Antibiotic-Resistant Bacteria. National action plan for combating antibiotic-resistant bacteria, 2020-2025. U.S. Department of Health & Human Services; 2020.
  185. Centers for Disease Control and Prevention. Facility guidance for control of Carbapenem-resistant Enterobacteriaceae (CRE): November 2015 update - CRE toolkit. Centers for Disease Control and Prevention; 2015.
  186. Minnesota Department of Health. Recommendations for the management of carbapenem-resistant Enterobacteriaceae (CRE) in acute and long-term acute care hospitals. Minnesota Department of Health; 2013.
  187. National Health Service. The management of carbapenem resistant organisms (CRO) policy. National Health Service; 2022.
    CrossRef
  188. UK Health Security Agency. Framework of actions to contain carbapenemase-producing Enterobacterales. UK Health Security Agency; 2022.
    CrossRef
  189. Schwaber MJ, Carmeli Y. The impact of a carbapenem-resistant Enterobacteriaceae outbreak on facilitating development of a national infrastructure for infection control in Israel. Clin Infect Dis 2017;65:2144-9.
    Pubmed CrossRef
  190. Ben-David D, Masarwa S, Fallach N, et al. National policy for carbapenem-resistant Enterobacteriaceae (CRE) clearance and discontinuation of contact precautions for CRE carriers in post-acute care hospitals in Israel: impact on isolation-days and new acquisitions. Clin Infect Dis 2021;72:829-35.
    Pubmed CrossRef
  191. Schwaber MJ, Lev B, Israeli A, et al. Containment of a country-wide outbreak of carbapenem-resistant Klebsiella pneumoniae in Israeli hospitals via a nationally implemented intervention. Clin Infect Dis 2011;52:848-55.
    Pubmed CrossRef
  192. Ben-David D, Masarwa S, Fallach N, et al. Success of a national intervention in controlling carbapenem-resistant Enterobacteriaceae in Israel's long-term care facilities. Clin Infect Dis 2019;68:964-71.
    Pubmed CrossRef
  193. World Health Organization. Guidelines for the prevention and control of carbapenem-resistant Enterobacteriaceae, Acinetobacter baumannii and Pseudomonas aeruginosa in health care facilities. World Health Organization; 2017.
  194. Magiorakos AP, Burns K, Rodríguez Baño J, et al. Infection prevention and control measures and tools for the prevention of entry of carbapenem-resistant Enterobacteriaceae into healthcare settings: guidance from the European Centre for Disease Prevention and Control. Antimicrob Resist Infect Control 2017;6:113.
    Pubmed KoreaMed CrossRef
  195. Yang G, Cintina I, Pariser A, Oehrlein E, Sullivan J, Kennedy A. The national economic burden of rare disease in the United States in 2019. Orphanet J Rare Dis 2022;17:163.
    Pubmed KoreaMed CrossRef
  196. Korea Disease Control and Prevention Agency. Annual report on the rare disease patients in Korea. Korea Disease Control and Prevention Agency; 2022.
    CrossRef
  197. Kang DY, Min SH, Park SK. The Korean economy: one year after the COVID-19 outbreak - an interim review of the pandemic's economic impact. Korea Institute for Industrial Economics and Trade; 2021.
    CrossRef
  198. Rafiq S, Swiston A. Mountains after mountains: Korea is containing COVID-19 and looking ahead. International Monetary Fund; 2021.
  199. Kyler J. Assessing your external environment: STEEP analysis. Competia; 2003.
  200. Proportion of elderly population aged 65 or older [Internet]. Statistics Korea; 2022 [cited 2023 Nov 22].
    Available from: https://kosis.kr/statHtml/statHtml.do?orgId=101&tblId=DT_1YL20631&conn_path=I2
  201. World Health Organization. Preparedness and resilience for emerging threats (PRET) [Internet]. World Health Organization; 2023 [cited 2023 Nov 22].
    Available from: https://www.who.int/initiatives/preparedness-and-resilience-for-emerging-threats
  202. Korea Disease Control and Prevention Agency. Current status and issues of chronic diseases in 2022. Korea Disease Control and Prevention Agency; 2022.
  203. Lee Y, Kim S, Hwang N, et al. 2020 The Korean elderly survey. Ministry of Health and Welfare; 2020.
  204. Statistics Korea. Annual report on the cause of death statistics. Statistics Korea; 2022.
  205. Statistics Korea. Annual report for elderly population. Statistics Korea; 2022.
    CrossRef
  206. Lee MS, Lee KS, Lee JJ, et al. Directions and current issues on the policy of prevention and management for hypertension and diabetes, and development of chronic disease prevention and management model in Korea. J Agric Med Community Health 2020;45:13-40.
  207. Korea Disease Control and Prevention Agency. Korea community health at a glance 2022: Korea Community Health Survey (KCHS). Korea Disease Control and Prevention Agency; 2023.
  208. Gyeongsangbuk-do Provincial Government. The 7th community health plan in Gyeongsangbuk-do. Gyeongsangbuk-do Provincial Government; 2019.
  209. Gyeongsangbuk-do Provincial Government. The 8th community health plan in Gyeongsangbuk-do. Gyeongsangbuk-do Provincial Government; 2023.
  210. Hyun S, Woo D, Park S. The effect of interaction between obesity and grip strength on health-related quality of life in elderly: based on the Korea National Health and Nutrition Examination Survey (2016-2018). J Health Inf Stat 2021;46:28-35.
    CrossRef
  211. Cha GH, Lim SH. Analysis of population changes and estimation of regional vitality index of small cities in non-metropolitan area. Geogr J Korea 2023;57:111-28.
    CrossRef
  212. Sejong City. The 8th (2023~2026) community health plan. Sejong City; 2023.
  213. Chungcheongnam-do. The 8th community health plan (2023~2026). Chungcheongnam-do; 2023.
  214. Chungcheongbuk-do. The 8th community health plan (2023~2026). Chungcheongbuk-do; 2023.
  215. Daejeon Metropolitan City. The 8th community health plan (2023~2026). Daejeon Metropolitan City; 2023.
  216. Lee JR. Review the change of chronic disease care in Korea. J Korean Diabetes 2022;23:251-7.
    CrossRef
  217. Kim S, Nho SJ, Kim YR, Kim J. The current status and task of non-communicable disease prevention and management of the Capital Regional Center for Disease Control and Prevention. Public Health Wkly Rep 2022;15:2835-49.
  218. National Evidence-based Healthcare Collaborating Agency. Development of Chronic Disease Management Service Model centered on primary care. National Evidence-based Healthcare Collaborating Agency; 2016.
  219. Kim HS, Yoo BN, Lee EW. Evaluation of the national chronic diseases management policy: performance and future directions. Public Health Aff 2018;2:105-20.
    CrossRef
  220. Korea Disease Control and Prevention Agency Press Release [cited 2024 Feb 5]
    Available from: https://daegucidcp.kr/zbbs/dn.php?tb=zbbs_report&rowid=892&num=0&dn=1
  221. Raoofi S, Pashazadeh Kan F, Rafiei S, et al. Global prevalence of nosocomial infection: a systematic review and meta-analysis. PLoS One 2023;18:e0274248.
    Pubmed KoreaMed CrossRef
  222. Korea Disease Control and Prevention Agency Press Release. 2023 [cited 2023 Nov 22].
    Available from: https://www.kdca.go.kr/board/board.es?mid=a20501010000&bid=0015&list_no=722943&cg_code=&act=view&nPage=23
  223. O'Boyle C, Soule BM. Reflecting on the future of infection prevention and control: are we waiting or creating?. Am J Infect Control 2009;37:613-4.
    Pubmed KoreaMed CrossRef
  224. History of IIPW [Internet]. Association for Professionals in Infection Control and Epidemiology; 2023 [cited 2023 Nov 22].
    Available from: https://infectionpreventionandyou.org/history/
  225. World Health Organization (WHO). MERS situation update, December 2022 [Internet]. WHO; 2022 [cited 2023 Nov 17].
    Available from: https://applications.emro.who.int/docs/WHOEMCSR630E-eng.pdf?ua=1
  226. Korea Disease Control and Prevention Agency. MERS manual. Korea Disease Control and Prevention Agency; 2022.
  227. Cha JO, Seo YJ, Kang SK, Kim I, Gwack J. Sentinel surveillance results for influenza and acute respiratory infections during the coronavirus disease 2019 pandemic. Public Health Wkly Rep 2023;16:597-612.
  228. Choi SK, Kim JA, Lee SY, Gwack J. The results of national surveillance and response to the Middle East Respiratory Syndrome (MERS) patients under investigation (PUIs) cases in the Republic of Korea, 2019-2021. Public Health Wkly Rep 2022;15:1018-30.
    CrossRef
  229. Ryu BY, Kim EK, Shin SH, et al. Results of national surveillance and response on patients under investigation (PUIs) of Middle East respiratory syndrome coronavirus (MERS-CoV) infection in Korea, 2018. Public Health Wkly Rep 2019;12:402-9.
    CrossRef
  230. Hammond A, Laurenson-Schafer H, Marsland M, et al. Review of the 2017-2018 influenza season in the northern hemisphere. Wkly Epidemiol Rec 2018;93:429-44.
  231. Statistics Korea. Annual report on the causes of death statistics in 2019 [Internet]. Statistics Korea; 2020 [cited 2023 Oct 16].
    Available from: https://kostat.go.kr/board.es?mid=a10301060100&bid=218&act=view&list_no=385219&tag=&nPage=1&ref_bid=
  232. Korea Disease Control and Prevention AgencyNational Fire Agency. 2021 Sudden cardiac arrest survey statistics. Korea Disease Control and Prevention Agency; 2022.
  233. Kim GC, Kim SY, Kim JW, et al. Variance of the COVID-19 occurrence in the community: influence on the emergency medical service and the survival of out-of-hospital cardiac arrest patients. J Korean Soc Emerg Med 2023;34:96-104.
    Pubmed KoreaMed CrossRef
  234. Shin WM, Kim JM, Park CY, Shin EH, Tchoe BH. Analysis of factors influencing the survival of patients with Out-of-Hospital of Cardiac Arrest (OHCA). Korean Public Health Res 2020;46:93-105.
  235. Ryu JH, Kim JH, Ryoo HW, et al. Out-of-hospital cardiac arrest outcomes according to the time of day: a citywide multicenter retrospective observational study. J Korean Soc Emerg Med 2022;33:28-36.
  236. Kim HS, Chun JH. Determinants on survival outcomes of sudden out-of-hospital cardiac arrest: a multilevel analysis. Korean J Emerg Med Serv 2020;24:7-26.
  237. Myat A, Song KJ, Rea T. Out-of-hospital cardiac arrest: current concepts. Lancet 2018;391:970-9.
    Pubmed CrossRef
  238. Kim SH. Factors affecting recovery of spontaneous circulation in patients before cardiac arrest in emergency department: 2012~2016 focused on medical records data. Korean Soc Law Med 2018;19:209-33.
    CrossRef
  239. Lee YK, Nho TH, Park YS, et al. Enhanced strategies through national tri-temporal analysis of public capacity prepared for laypersons' cardiopulmonary resuscitation. J Korean Soc Emerg Med 2016;27:549-55.
  240. Reynolds JC, Grunau BE, Rittenberger JC, Sawyer KN, Kurz MC, Callaway CW. Association between duration of resuscitation and favorable outcome after out-of-hospital cardiac arrest: implications for prolonging or terminating resuscitation. Circulation 2016;134:2084-94.
    Pubmed KoreaMed CrossRef
  241. Laboratory quality assurance and standardization programs [Internet]. Centers for Disease Control and Prevention; 2023 [cited 2023 Nov 8].
    Available from: https://www.cdc.gov/labstandards/index.html
  242. What do CDC CSPs offer? [Internet]. Centers for Disease Control and Prevention; 2023 [cited 2023 Nov 8].
    Available from: https://www.cdc.gov/labstandards/csp/csp_offerings.html
  243. UK Standards for Microbiology Investigations: quality assurance in the diagnostic infection sciences laboratory [Internet]. Public Health England; 2021 [cited 2023 Nov 8].
    Available from: https://assets.publishing.service.gov.uk/media/60faa19ee90e0703bbd94a4e/Q_2i8.pdf
  244. UK Standards for Microbiology Investigations: quality assurance in the diagnostic virology and serology laboratory [Internet]. Public Health England; 2021 [cited 2023 Nov 8].
    Available from: https://assets.publishing.service.gov.uk/media/60819ad18fa8f51b8f716c7c/Q_2do+.pdf
  245. Ahmad-Nejad P, Ashavaid T, Vacaflores Salinas A, et al. Current and future challenges in quality assurance in molecular diagnostics. Clin Chim Acta 2021;519:239-46.
    Pubmed CrossRef
  246. Infectious Disease Control and Prevention Act, Act No. 19419 (May 19, 2023).
  247. Park JS, Park YE, Kim GJ, Lee S. Accreditation system for national reference laboratories for infectious diseases. Public Health Wkly Rep 2019;12:1314-9.
  248. Regulations on Accreditation and Operation of National Reference Laboratory for Infectious Diseases, KDCA Act No. 97 (Apr. 28, 2022).
  249. What is Rare Disease Day? [Internet]. Rare Disease Day; 2024 [cited 2024 Jan 11].
    Available from: https://www.rarediseaseday.org/what-is-rare-disease-day/
  250. Rare Disease Day 2023: our global community comes together for a more equitable world [Internet]. EURORDIS-Rare Diseases Europe; 2023 [cited 2024 Jan 11].
    Available from: https://www.eurordis.org/rare-disease-day-2023-our-global-community-comes-together/
  251. Share your Colours poster [Internet]. Rare Disease Day; 2024 [cited 2024 Jan 12].
    Available from: https://www.rarediseaseday.org/downloads/
  252. Korea Disease Control and Prevention Agency Press Release. 2024 [cited 2024 Jan 12].
    Available from: https://www.kdca.go.kr/board/board.es?mid=a20501010000&bid=0015&list_no=722604&cg_code=&act=view&nPage=44#
  253. Korea Disease Control and Prevention Agency Press Release. 2024 [cited 2024 Jan 12].
    Available from: https://www.kdca.go.kr/board/board.es?mid=a20501010000&bid=0015&list_no=723946&cg_code=&act=view&nPage=12
  254. Ministry of Health and Welfare Press Release. 2024 [cited 2024 Jan 11].
    Available from: https://www.mohw.go.kr/board.es?mid=a10503010100&bid=0027&act=view&list_no=370404&tag=&nPage=156
  255. Lee JS. Genetic understanding of rare incurable diseases and considerations when reflecting health insurance policies. HIRA Policy Brief 2016;10:22-30.
  256. Ramos-Fuentes F, González-Meneses A, Ars E, Hernández-Jaras J. Genetic diagnosis of rare diseases: past and present. Adv Ther 2020;37(Suppl 2):29-37.
    Pubmed CrossRef
  257. Rehder C, Bean LJH, Bick D, et al. Next-generation sequencing for constitutional variants in the clinical laboratory, 2021 revision: a technical standard of the American College of Medical Genetics and Genomics (ACMG). Genet Med 2021;23:1399-415.
    Pubmed CrossRef
  258. Boycott KM, Vanstone MR, Bulman DE, MacKenzie AE. Rare-disease genetics in the era of next-generation sequencing: discovery to translation. Nat Rev Genet 2013;14:681-91.
    Pubmed CrossRef
  259. Korean Society of Medical Genetics and Genomics (KSMG) [Internet]. Korean Society of Medical Genetics and Genomics [cited 2023 Dec 1].
    Available from: http://www.ksmg.or.kr
  260. American Board of Genetic Counseling (ABGC) [Internet]. American Board of Genetic Counseling [cited 2023 Dec 1].
    Available from: https://www.abgc.net
  261. Genetic Counsellor Registration Board (GCRB) [Internet]. Genetic Counsellor Registration Board [cited 2023 Dec 1].
    Available from: https://gcrb.org.uk
  262. National Society of Genetic Counselors (NSGC) [Internet]. National Society of Genetic Counselors [cited 2023 Dec 1].
    Available from: https://www.nsgc.org
  263. Japanese Society for Genetic Counseling [Internet]. Japanese Society for Genetic Counseling [cited 2023 Dec 1].
    Available from: http://www.jsgc.jp
  264. World Health Organization. Report on the burden of endemic health care-associated infection worldwide. World Health Organization; 2011.
    CrossRef
  265. Kim HB. Clinical and economic burden of infection with six multi-drug resistant organisms. Korea Centers for Disease Control and Prevention; 2018.
  266. World Health Organization. Global report on infection prevention and control. World Health Organization; 2022.
  267. Korea Disease Control and Prevention Agency. 2021 National Surveillance of Infection Control in healthcare facilities [Internet]. Korea Disease Control and Prevention Agency; 2022 [cited 2022 Dec 16].
    Available from: https://www.kdca.go.kr/contents.es?mid=a20301080200
  268. Aghdassi SJS, Hansen S, Bischoff P, Behnke M, Gastmeier P. A national survey on the implementation of key infection prevention and control structures in German hospitals: results from 736 hospitals conducting the WHO Infection Prevention and Control Assessment Framework (IPCAF). Antimicrob Resist Infect Control 2019;8:73.
    Pubmed KoreaMed CrossRef
  269. Aghdassi SJS, Grisold A, Wechsler-Fördös A, et al. Evaluating infection prevention and control programs in Austrian acute care hospitals using the WHO Infection Prevention and Control Assessment Framework. Antimicrob Resist Infect Control 2020;9:92.
    Pubmed KoreaMed CrossRef
  270. Oppong TB, Amponsem-Boateng C, Kyere EKD, et al. Infection prevention and control preparedness level and associated determinants in 56 acute healthcare facilities in Ghana. Infect Drug Resist 2020;13:4263-71.
    Pubmed KoreaMed CrossRef
  271. Housing census [Internet]. Statistics Korea; 2005 [cited 2022 Jan 20].
    Available from: https://www.k-stat.go.kr/metasvc/msda100/worddc
  272. Distribution of households by household size - EU-SILC survey [Internet]. Eurostat; 2022 [cited 2022 Jan 20].
    Available from: https://ec.europa.eu/eurostat/databrowser/view/ilc_lvph03/default/table?lang=en
  273. Statistics Korea. Household Projections: 2017-2047. Statistics Korea; 2019.
  274. Jeong S, Cho SI. Effects of living alone versus with others and of housemate type on smoking, drinking, dietary habits, and physical activity among elderly people. Epidemiol Health 2017;39:e2017034.
    Pubmed KoreaMed CrossRef
  275. Widhowati SS, Chen CM, Chang LH, Lee CK, Fetzer S. Living alone, loneliness, and depressive symptoms among Indonesian older women. Health Care Women Int 2020;41:984-96.
    Pubmed CrossRef
  276. Chou KL, Ho AH, Chi I. Living alone and depression in Chinese older adults. Aging Ment Health 2006;10:583-91.
    Pubmed CrossRef
  277. Noh JW, Hong JH, Kim IH, Choi M, Kwon YD. Relationship between number of household members and prevalence of chronic diseases: a cross-sectional analysis of Korea Health Panel data. Popul Health Manag 2017;20:165.
    Pubmed CrossRef
  278. Kikuchi H, Takamiya T, Odagiri Y, et al. Gender differences in association between psychological distress and detailed living arrangements among Japanese older adults, aged 65-74 years. Soc Psychiatry Psychiatr Epidemiol 2014;49:823-30.
    Pubmed CrossRef
  279. Honjo K, Tani Y, Saito M, et al. Living alone or with others and depressive symptoms, and effect modification by residential social cohesion among older adults in Japan: the JAGES longitudinal study. J Epidemiol 2018;28:315-22.
    Pubmed KoreaMed CrossRef
  280. Oh DH, Park JH, Lee HY, Kim SA, Choi BY, Nam JH. Association between living arrangements and depressive symptoms among older women and men in South Korea. Soc Psychiatry Psychiatr Epidemiol 2015;50:133-41.
    Pubmed CrossRef
  281. Jacob L, Haro JM, Koyanagi A. Relationship between living alone and common mental disorders in the 1993, 2000 and 2007 National Psychiatric Morbidity Surveys. PLoS One 2019;14:e0215182.
    Pubmed KoreaMed CrossRef
  282. Lim LL, Kua EH. Living alone, loneliness, and psychological well-being of older persons in singapore. Curr Gerontol Geriatr Res 2011;2011:673181.
    Pubmed KoreaMed CrossRef
  283. Farrer L, Leach L, Griffiths KM, Christensen H, Jorm AF. Age differences in mental health literacy. BMC Public Health 2008;8:125.
    Pubmed KoreaMed CrossRef
  284. Kessler RC, Birnbaum HG, Shahly V, et al. Age differences in the prevalence and co-morbidity of DSM-IV major depressive episodes: results from the WHO World Mental Health Survey Initiative. Depress Anxiety 2010;27:351-64.
    Pubmed KoreaMed CrossRef
  285. Cuijpers P, Karyotaki E, Eckshtain D, et al. Psychotherapy for depression across different age groups: a systematic review and meta-analysis. JAMA Psychiatry 2020;77:694-702.
    Pubmed KoreaMed CrossRef
  286. Lin PC, Wang HH. Factors associated with depressive symptoms among older adults living alone: an analysis of sex difference. Aging Ment Health 2011;15:1038-44.
    Pubmed CrossRef
  287. Byun M. Single person household and urban policy in Seoul. Korean J Cult Soc Issues 2015;21:551-73.
    CrossRef
  288. Oshio T, Kan M. Which is riskier for mental health, living alone or not participating in any social activity? Evidence from a population-based eleven-year survey in Japan. Soc Sci Med 2019;233:57-63.
    Pubmed CrossRef
  289. Joutsenniemi K, Martelin T, Martikainen P, Pirkola S, Koskinen S. Living arrangements and mental health in Finland. J Epidemiol Community Health 2006;60:468-75.
    Pubmed KoreaMed CrossRef
  290. Steptoe A, Shankar A, Demakakos P, Wardle J. Social isolation, loneliness, and all-cause mortality in older men and women. Proc Natl Acad Sci U S A 2013;110:5797-801.
    Pubmed KoreaMed CrossRef
  291. Coyle CE, Dugan E. Social isolation, loneliness and health among older adults. J Aging Health 2012;24:1346-63.
    Pubmed CrossRef
  292. Shankar A, McMunn A, Banks J, Steptoe A. Loneliness, social isolation, and behavioral and biological health indicators in older adults. Health Psychol 2011;30:377-85.
    Pubmed CrossRef
  293. Kim AN. An empirical analysis on social exclusion in Korea. Korean J Soc Theory 2007;32:227-54.
  294. Jang YM. A study on the effects to the change of social capital from participation in elderly employment programs. Korean J Soc Welf 2011;63:261-89.
    CrossRef
  295. Spitzer RL, Kroenke K, Williams JB. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA 1999;282:1737-44.
    Pubmed CrossRef
  296. Lee S, Huh Y, Kim J, Han C. Finding optimal cut off points of the Korean version of the Patient Health Questionnaire-9(PHQ-9) for screening depressive disorders. J Korean Soc Depress Bipolar Disord 2014;12:32-6.
  297. Cornwell EY, Waite LJ. Social disconnectedness, perceived isolation, and health among older adults. J Health Soc Behav 2009;50:31-48.
    Pubmed KoreaMed CrossRef
  298. Leigh-Hunt N, Bagguley D, Bash K, et al. An overview of systematic reviews on the public health consequences of social isolation and loneliness. Public Health 2017;152:157-71.
    Pubmed CrossRef
  299. Quach LT, Burr JA. Perceived social isolation, social disconnectedness and falls: the mediating role of depression. Aging Ment Health 2021;25:1029-34.
    Pubmed KoreaMed CrossRef
  300. Robb CE, de Jager CA, Ahmadi-Abhari S, et al. Associations of social isolation with anxiety and depression during the early COVID-19 pandemic: a survey of older adults in London, UK. Front Psychiatry 2020;11:591120.
    Pubmed KoreaMed CrossRef
  301. Santini ZI, Jose PE, Cornwell EY, et al. Social disconnectedness, perceived isolation, and symptoms of depression and anxiety among older Americans (NSHAP): a longitudinal mediation analysis. Lancet Public Health 2020;5:e62-70.
    Pubmed CrossRef
  302. Teo AR. Social isolation associated with depression: a case report of hikikomori. Int J Soc Psychiatry 2013;59:339-41.
    Pubmed KoreaMed CrossRef
  303. Kang E, Lee M. Single-person households in South Korea and their policy implications. Health Welf Policy Forum 2016;234:47-56.
  304. Smith KJ, Victor C. Typologies of loneliness, living alone and social isolation, and their associations with physical and mental health. Ageing Soc 2019;39:1709-30.
    CrossRef
  305. Chan A, Malhotra C, Malhotra R, Østbye T. Living arrangements, social networks and depressive symptoms among older men and women in Singapore. Int J Geriatr Psychiatry 2011;26:630-9.
    Pubmed CrossRef
  306. Song N. An analysis on the depression of single-person household by age groups. J Humanit Soc Sci 2020;11:405-20.
    CrossRef
  307. Valtorta NK, Kanaan M, Gilbody S, Hanratty B. Loneliness, social isolation and social relationships: what are we measuring? A novel framework for classifying and comparing tools. BMJ Open 2016;6:e010799.
    Pubmed KoreaMed CrossRef
  308. Wang J, Lloyd-Evans B, Giacco D, et al. Social isolation in mental health: a conceptual and methodological review. Soc Psychiatry Psychiatr Epidemiol 2017;52:1451-61.
    Pubmed KoreaMed CrossRef
  309. Byun MR, Shin SY, Cho KJ. Single-person households, changing Seoul. Policy Rep 2009;(30):1-18.
    CrossRef
  310. Lee Y. One-person households and their policy implications. Health Welf Policy Forum 2017;252:64-77.
  311. Choi JY. A study on solitary death prevention policies [master's thesis]. Yonsei University; 2018.
  312. Shin HJ. A study on the changing current situation in lonely death and its measures in Korean society. Korean Crim Psychol Rev 2018;14:63-78.
    CrossRef
  313. Elbay RY, Kurtulmuş A, Arpacıoğlu S, Karadere E. Depression, anxiety, stress levels of physicians and associated factors in Covid-19 pandemics. Psychiatry Res 2020;290:113130.
    Pubmed KoreaMed CrossRef
  314. Sigdel A, Bista A, Bhattarai N, et al. Depression, anxiety and depression-anxiety comorbidity amid COVID-19 pandemic: an online survey conducted during lockdown in Nepal. MedRxiv [Preprint]. 2020 [cited 2021 Dec 1].
    Available from: https://doi.org/10.1101/2020.04.30.20086926
    CrossRef
  315. NHS England. Social prescribing and community-based support: summary guide. NHS England; 2019.
  316. Hassan SM, Giebel C, Morasae EK, et al. Social prescribing for people with mental health needs living in disadvantaged communities: the Life Rooms model. BMC Health Serv Res 2020;20:19.
    Pubmed KoreaMed CrossRef
  317. Robertson BH, Jansen RW, Khanna B, et al. Genetic relatedness of hepatitis A virus strains recovered from different geographical regions. J Gen Virol 1992;73:1365-77.
    Pubmed CrossRef
  318. Hall E, Wodi AP, Hamborsky J, Morelli V, Schillie S. Epidemiology and prevention of vaccine-preventable diseases. 14th ed. Centers for Disease Control and Prevention. 2021.
    CrossRef
  319. Cho KY. Hepatitis A. Korean J Pediatr Gastroenterol Nutr 2010;13(Suppl 1):S70-7.
    CrossRef
  320. Kang SH, Kim MY, Baik SK. Perspectives on acute hepatitis a control in Korea. J Korean Med Sci 2019;34:e230.
    Pubmed KoreaMed CrossRef
  321. Korea Disease Control and Prevention Agency. White paper 2022. Korea Disease Control and Prevention Agency; 2023.
  322. World Health Organization. The global prevalence of hepatitis A virus infection and susceptibility: a systematic review. World Health Organization; 2010.
  323. Lee H, Cho HK, Kim JH, Kim KH. Seroepidemiology of hepatitis A in Korea: changes over the past 30 years. J Korean Med Sci 2011;26:791-6.
    Pubmed KoreaMed CrossRef
  324. Choi BY. Changing patterns of hepatitis A virus infection in Korea. . Korean J Med 2008;75 Suppl 2:S656-60.
  325. Park JH. Changes in the seroprevalence of hepatitis A virus antibody in Korea. Korean J Hepatol 2007;13:1-4.
    Pubmed CrossRef
  326. Ha J, Choi M, Yu D, Park N. Status of infectious diseases reporting in 2022. Public Health Wkly Rep 2023;16:1275-85.
  327. Chung J, Seo S, Park E, Cho S, Lee M, Gwack J. Surveillance and epidemiological characteristics of hepatitis E in the Republic of Korea. Public Health Wkly Rep 2023;16:1-15.
  328. Statistics Korea. Cause of deaths statistics in 2022. Statistics Korea; 2023.
  329. Micro Data Integrated Service (MDIS) [Internet]. Statistics Korea; 2023 [cited 2023 Oct 23].
    Available from: https://mdis.kostat.go.kr/
  330. Korean Statistical Information Service (KOSIS) [Internet]. Statistics Korea; 2023 [cited 2023 Oct 23].
    Available from: https://kosis.kr
  331. Korea Disease Control and Prevention Agency. The Third National Strategic Plan for TB Control in Republic of Korea, 2023~2027 [Internet]. Korea Disease Control and Prevention Agency; 2023 [cited 2023 Oct 23].
    Available from: https://www.kdca.go.kr/gallery.es?mid=a20503010000&bid=0002&act=view&list_no=146078
  332. Korea Disease Control and Prevention Agency. Annual report on the notified tuberculosis in Korea, 2022. Korea Disease Control and Prevention Agency; 2023.
    CrossRef
  333. World Health Organization. Global tuberculosis report 2023 [Internet]. World Health Organization; 2023 [cited 2023 Nov 30].
    Available from: https://www.who.int/teams/global-tuberculosis-programme/tb-reports/global-tuberculosis-report-2023
  334. United Nations. Political declaration of the high-level meeting of the General Assembly on the fight against tuberculosis: resolution [Internet]. United Nations; 2018 [cited 2023 Nov 30].
    Available from: https://digitallibrary.un.org/record/1649568?ln=en
  335. United Nations. Political declaration of the high-level meeting on the fight against tuberculosis: resolution [Internet]. United Nations; 2023 [cited 2023 Nov 30].
    Available from: https://digitallibrary.un.org/record/4025280?ln=en
  336. World Health Organization. Tuberculosis data [Internet]. World Health Organization; 2023 [cited 2023 Nov 30].
    Available from: https://www.who.int/teams/global-tuberculosis-programme/data
  337. Korea Disease Control and Prevention Agency Press Release [cited 2023 Nov 30]
    Available from: https://www.kdca.go.kr/board/board.es?mid=a20501010000&bid=0015&list_no=723534&cg_code=&act=view&nPage=1
  338. World Health Organization (WHO). Influenza laboratory surveillance information: virus detections by subtype reported to FluNet [Internet]. World Health Organization; 2023 [cited 2023 Dec 11].
    Available from: https://app.powerbi.com/view?r=eyJrIjoiZTkyODcyOTEtZjA5YS00ZmI0LWFkZGUtODIxNGI5OTE3YjM0IiwidCI6ImY2MTBjMGI3LWJkMjQtNGIzOS04MTBiLTNkYzI4MGFmYjU5MCIsImMiOjh9
  339. Kim HM, Lee NJ, Kim MS, Kang C, Chung YS. Detection of neuraminidase inhibitors-resistant influenza virus through genetic and phenotypic analysis in Korea. Public Health Wkly Rep 2019;12:410-5.
  340. Lee NJ, Woo SH, Lee JH, Rhee JE, Kim EJ. 2021-2022 Influenza and respiratory viruses laboratory surveillance report in the Republic of Korea. Public Health Wkly Rep 2023;16:53-65.
  341. Ben Moussa M, Buckrell S, Rahal A, et al. National influenza mid-season report, 2022-2023: a rapid and early epidemic onset. Can Commun Dis Rep 2023;49:10-4.
    Pubmed KoreaMed CrossRef
  342. World Health Organization (WHO). Recommended composition of influenza virus vaccines for use in the 2023-2024 northern hemisphere influenza season. World Health Organization; 2023.
  343. Kim HM, Rhee JE, Lee NJ, et al. Recent increase in the detection of human parainfluenza virus during the coronavirus disease-2019 pandemic in the Republic of Korea. Virol J 2022;19:215.
    Pubmed KoreaMed CrossRef
  344. Olsen SJ, Winn AK, Budd AP, et al. Changes in influenza and other respiratory virus activity during the COVID-19 pandemic - United States, 2020-2021. MMWR Morb Mortal Wkly Rep 2021;70:1013-9.
    Pubmed KoreaMed CrossRef
  345. Limb M. RSV: the year the respiratory infection "took its gloves off". BMJ 2021;374:n2078.
    Pubmed CrossRef
  346. Eden JS, Sikazwe C, Xie R, et al. Off-season RSV epidemics in Australia after easing of COVID-19 restrictions. Nat Commun 2022;13:2884.
    Pubmed KoreaMed CrossRef
  347. Chow EJ, Uyeki TM, Chu HY. The effects of the COVID-19 pandemic on community respiratory virus activity. Nat Rev Microbiol 2023;21:195-210.
    Pubmed KoreaMed CrossRef

Article

Erratum

Public Health Weekly Report 2024; 17(12): 471-471

Published online March 28, 2024 https://doi.org/10.56786/PHWR.2024.17.12.3

Copyright © The Korea Disease Control and Prevention Agency.

저자 오류 보고: 제17권 제10호

This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

https://doi.org/10.56786/PHWR.2024.17.10.2

Public Health Wkly Rep 2024;17(10):404-417

주간 건강과 질병 제17권 제10호의 ‘[조사/감시 보고] 국내 A형간염 개별 사례의 특성 및 집단발생 양상 파악, 2019-2022년’ 논문 저자의 성명이 개명됨에 따라 다음과 같이 수정합니다.

1. 저자명(p.404)

김하연, 채승훈, 양진선*

2. Author name (p.411)

Ha Yeon Kim, Seung-Hoon Chae, Jin Seon Yang*

3. Author Contributions (p.410, 417)

Conceptualization: HYK, SHC, JSY. Data curation: HYK. Formal analysis: HYK. Methodology: HYK, SHC. Project administration: HYK SHC, JSY. Supervision: JSY, SHC. Visualization: HYK. Writing – original draft: HYK. Writing – review & editing: HYK, SHC, JSY.

References

  1. Alman BL, Stingone JA, Yazdy M, et al. Associations between PM2.5 and risk of preterm birth among liveborn infants. Ann Epidemiol 2019;39:46-53.e2.
    Pubmed KoreaMed CrossRef
  2. Arroyo V, Díaz J, Carmona R, Ortiz C, Linares C. Impact of air pollution and temperature on adverse birth outcomes: Madrid, 2001-2009. Environ Pollut 2016;218:1154-61.
    Pubmed CrossRef
  3. Arroyo V, Díaz J, Ortiz C, Carmona R, Sáez M, Linares C. Short term effect of air pollution, noise and heat waves on preterm births in Madrid (Spain). Environ Res 2016;145:162-8.
    Pubmed CrossRef
  4. Avalos LA, Chen H, Li DK, Basu R. The impact of high apparent temperature on spontaneous preterm delivery: a case-crossover study. Environ Health 2017;16:5.
    Pubmed KoreaMed CrossRef
  5. Basagaña X, Michael Y, Lensky IM, et al. Low and high ambient temperatures during pregnancy and birth weight among 624,940 singleton term births in Israel (2010-2014): an investigation of potential windows of susceptibility. Environ Health Perspect 2021;129:107001.
    Pubmed KoreaMed CrossRef
  6. Basu R, Rau R, Pearson D, Malig B. Temperature and term low birth weight in California. Am J Epidemiol 2018;187:2306-14.
    Pubmed CrossRef
  7. Bekkar B, Pacheco S, Basu R, DeNicola N. Association of air pollution and heat exposure with preterm birth, low birth weight, and stillbirth in the US: a systematic review. JAMA Netw Open 2020;3:e208243. Erratum in: JAMA Netw Open 2020;3:e2014510.
    Pubmed KoreaMed CrossRef
  8. Bernstein AS, Sun S, Weinberger KR, Spangler KR, Sheffield PE, Wellenius GA. Warm season and emergency department visits to U.S. children's hospitals. Environ Health Perspect 2022;130:17001. Erratum in: Environ Health Perspect 2022;130:49002.
    Pubmed KoreaMed CrossRef
  9. Bhaskaran K, Gasparrini A, Hajat S, Smeeth L, Armstrong B. Time series regression studies in environmental epidemiology. Int J Epidemiol 2013;42:1187-95.
    Pubmed KoreaMed CrossRef
  10. World Health Organization (WHO). Global action plan for the prevention and control of noncommunicable diseases 2013-2020. WHO; 2013.
  11. Ministry of Health and WelfareKorea Health Promotion Institute. The 5th national health plan (health plan 2030, 2021~2030). Korea Health Promotion Institute 2022; Rev. ed.
  12. Kim YT, Choi BY, Lee KO, et al. Overview of Korean community health survey. J Korean Med Assoc 2012;55:74-83.
    CrossRef
  13. World Health Organization (WHO). Noncommunicable diseases [Internet]. WHO; 2023 [cited 2023 Oct 30]. Available from: https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases
  14. Jekal Y, Lee MK, Kim ES, et al. Effects of walking and physical activity on glucose regulation among type 2 diabetics. Korean Diabetes J 2008;32:60-7.
    CrossRef
  15. Imkampe AK, Gulliford MC. Increasing socio-economic inequality in type 2 diabetes prevalence--repeated cross-sectional surveys in England 1994-2006. Eur J Public Health 2011;21:484-90.
    Pubmed CrossRef
  16. Jung CH, Son JW, Kang S, et al. Diabetes fact sheets in Korea, 2020: an appraisal of current status. Diabetes Metab J 2021;45:1-10.
    Pubmed KoreaMed CrossRef
  17. Lee MS, Lee KS, Lee JJ, et al. Directions and current issues on the policy of prevention and management for hypertension and diabetes, and development of chronic disease prevention and management model in Korea. J Agric Med Community Health 2020;45:13-40.
  18. The 2007 Recommendations of the International Commission on Radiological Protection. ICRP publication 103. Ann ICRP 2007;37:1-332.
    Pubmed CrossRef
  19. Medical service act, Act No.17787, Enforcement Date 2021 Jun 30. Article 37 [Internet]. Korea Legislation Research Institute; 2020 [cited 2022 Sep 23]. Available from: https://elaw.klri.re.kr/kor_service/lawView.do?hseq=60889&lang=ENG
  20. Korea Disease Control and Prevention Agency. 2019 Report occupational radiation exposure in diagnostic radiology in Korea. Korea Disease Control and Prevention Agency; 2020.
  21. Korea Disease Control and Prevention Agency. 2020 Report occupational radiation exposure in diagnostic radiology in Korea. Korea Disease Control and Prevention Agency; 2021.
  22. Korea Disease Control and Prevention Agency. 2021 Report occupational radiation exposure in diagnostic radiology in Korea. Korea Disease Control and Prevention Agency; 2022.
  23. Korea Disease Control and Prevention Agency. Korea health statistics 2021: Korea National Health and Nutrition Examination Survey (KNHANES VIII-3). Korea Disease Control and Prevention Agency; 2022.
  24. Haslam DW, James WP. Obesity. Lancet 2005;366:1197-209.
    Pubmed CrossRef
  25. Mayasari NR, Hu TY, Chao JC, et al. Associations of the pre-pregnancy weight status with anaemia and the erythropoiesis-related micronutrient status. Public Health Nutr 2021;24:6247-57.
    Pubmed CrossRef
  26. Ng KYB, Cherian G, Kermack AJ, et al. Systematic review and meta-analysis of female lifestyle factors and risk of recurrent pregnancy loss. Sci Rep 2021;11:7081.
    Pubmed KoreaMed CrossRef
  27. Park J, Han S, Jang HD, Shin G, Han K, Hong JY. Underweight as a risk factor for vertebral fractures in the South Korean population. Spine J 2023;23:877-84.
    Pubmed CrossRef
  28. Korean Society for the Study of Obesity. Quick reference guideline. Korean Society for the Study of Obesity; 2020.
  29. Ministry of Health and Welfare. Dietary reference intakes for Koreans. Ministry of Health and Welfare; 2015.
    CrossRef
  30. Cho YG. Why does weight gain put more stress on women?. Korean J Fam Med 2020;41:363-4.
    Pubmed KoreaMed CrossRef
  31. Kim D. Body image distortion and appearance management behaviors in women and their policy implications. Health Welf Policy Forum 2021;299:40-58.
  32. Park SY. Gender statistics. Body type polarization among Korean women: obese or underweight (2023).
  33. Noh JW, Kwon YD, Yang Y, Cheon J, Kim J. Relationship between body image and weight status in east Asian countries: comparison between South Korea and Taiwan. BMC Public Health 2018;18:814.
    Pubmed KoreaMed CrossRef
  34. Park B, Cho HN, Choi E, et al. Self-perceptions of body weight status according to age-groups among Korean women: a nationwide population-based survey. PLoS One 2019;14:e0210486.
    Pubmed KoreaMed CrossRef
  35. Park B, Cho HN, Choi E, et al. Weight control behaviors according to body weight status and accuracy of weight perceptions among Korean women: a nationwide population-based survey. Sci Rep 2019;9:9127.
    Pubmed KoreaMed CrossRef
  36. Montani JP, Schutz Y, Dulloo AG. Dieting and weight cycling as risk factors for cardiometabolic diseases: who is really at risk?. Obes Rev 2015;16 Suppl 1:7-18.
    Pubmed CrossRef
  37. Martin CB, Herrick KA, Sarafrazi N, Ogden CL. Attempts to lose weight among adults in the United States, 2013-2016. NCHS Data Brief 2018;(313):1-8.
    Pubmed
  38. Klos LA, Sobal J. Marital status and body weight, weight perception, and weight management among U.S. adults. Eat Behav 2013;14:500-7.
    Pubmed CrossRef
  39. Siu J, Giskes K, Turrell G. Socio-economic differences in weight-control behaviours and barriers to weight control. Public Health Nutr 2011;14:1768-78.
    Pubmed CrossRef
  40. Peralta RL, Barr PB. Gender orientation and alcohol-related weight control behavior among male and female college students. J Am Coll Health 2017;65:229-42.
    Pubmed CrossRef
  41. Kim JH. Associations between weight control behavior and health behaviors in Korean young women: 2013 Community Health Survey. J Korea Acad Ind Coop Soc 2015;16:4734-44.
    CrossRef
  42. Oh YS, Cho YG. Exploring the limitations in the use of online health information and future direction: focused on analysis of expert knowledge in the frame of ignorance. Health Soc Welf Rev 2019;39:358-93.
    CrossRef
  43. Choi SK, Kim HY, Hwang JN, et al. A study for improving health literacy. Korea Institute for Health and Social Affairs; 2020.
  44. Syed-Abdul S, Fernandez-Luque L, Jian WS, et al. Misleading health-related information promoted through video-based social media: anorexia on YouTube. J Med Internet Res 2013;15:e30.
    Pubmed KoreaMed CrossRef
  45. Choi SK, Chun HR, Choi EJ. Review of recent digital health literacy programs in Europe and the United States. Korean J Health Educ Promot 2022;39:15-28.
    CrossRef
  46. Sørensen K, Van den Broucke S, Fullam J, et al. Health literacy and public health: a systematic review and integration of definitions and models. BMC Public Health 2012;12:80.
    Pubmed KoreaMed CrossRef
  47. Korea Institute for Health and Social Affairs. Korea Disease Control and Prevention Agency; 2023 [cited 2023 Jul 10]. Available from: https://health.kdca.go.kr/
  48. Johnson JD, Case DO. Health information seeking. Peter Lang; 2012.
    CrossRef
  49. Korea Health Promotion Institute. The 5th National Health Plan (Health Plan 2030, 2021~2030). Seoul: Korea Health Promotion Institute; 2022 Apr. Report No.: 정책- 04-2022-008-01. 139 p.
  50. National Health Service. National Health Service. Content policy [Internet]. National Health Service; 2022 [cited 2023 Sep 8]. Available from: www.nhs.uk/our-policies/content-policy/
  51. Korea Disease Control and Prevention Agency Press Release. 2023 [cited 2023 Sep 8]. Available from: https://www.kdca.go.kr/board/board.es?mid=a20501010000&bid=0015&act=view&list_no=722564
  52. Alman BL, Stingone JA, Yazdy M, et al. Associations between PM2.5 and risk of preterm birth among liveborn infants. Ann Epidemiol 2019;39:46-53.e2.
    Pubmed KoreaMed CrossRef
  53. Arroyo V, Díaz J, Carmona R, Ortiz C, Linares C. Impact of air pollution and temperature on adverse birth outcomes: Madrid, 2001-2009. Environ Pollut 2016;218:1154-61.
    Pubmed CrossRef
  54. Arroyo V, Díaz J, Ortiz C, Carmona R, Sáez M, Linares C. Short term effect of air pollution, noise and heat waves on preterm births in Madrid (Spain). Environ Res 2016;145:162-8.
    Pubmed CrossRef
  55. Avalos LA, Chen H, Li DK, Basu R. The impact of high apparent temperature on spontaneous preterm delivery: a case-crossover study. Environ Health 2017;16:5.
    Pubmed KoreaMed CrossRef
  56. Basagaña X, Michael Y, Lensky IM, et al. Low and high ambient temperatures during pregnancy and birth weight among 624,940 singleton term births in Israel (2010-2014): an investigation of potential windows of susceptibility. Environ Health Perspect 2021;129:107001.
    Pubmed KoreaMed CrossRef
  57. Basu R, Rau R, Pearson D, Malig B. Temperature and term low birth weight in California. Am J Epidemiol 2018;187:2306-14.
    Pubmed CrossRef
  58. Bekkar B, Pacheco S, Basu R, DeNicola N. Association of air pollution and heat exposure with preterm birth, low birth weight, and stillbirth in the US: a systematic review. JAMA Netw Open 2020;3:e208243. Erratum in: JAMA Netw Open 2020;3:e2014510.
    Pubmed KoreaMed CrossRef
  59. Bernstein AS, Sun S, Weinberger KR, Spangler KR, Sheffield PE, Wellenius GA. Warm season and emergency department visits to U.S. children's hospitals. Environ Health Perspect 2022;130:17001. Erratum in: Environ Health Perspect 2022;130:49002.
    Pubmed KoreaMed CrossRef
  60. Bhaskaran K, Gasparrini A, Hajat S, Smeeth L, Armstrong B. Time series regression studies in environmental epidemiology. Int J Epidemiol 2013;42:1187-95.
    Pubmed KoreaMed CrossRef
  61. World Health Organization (WHO). Global action plan for the prevention and control of noncommunicable diseases 2013-2020. WHO; 2013.
  62. Ministry of Health and WelfareKorea Health Promotion Institute. The 5th national health plan (health plan 2030, 2021~2030). Korea Health Promotion Institute 2022; Rev. ed.
  63. Kim YT, Choi BY, Lee KO, et al. Overview of Korean community health survey. J Korean Med Assoc 2012;55:74-83.
    CrossRef
  64. World Health Organization (WHO). Noncommunicable diseases [Internet]. WHO; 2023 [cited 2023 Oct 30]. Available from: https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases
  65. Jekal Y, Lee MK, Kim ES, et al. Effects of walking and physical activity on glucose regulation among type 2 diabetics. Korean Diabetes J 2008;32:60-7.
    CrossRef
  66. Imkampe AK, Gulliford MC. Increasing socio-economic inequality in type 2 diabetes prevalence--repeated cross-sectional surveys in England 1994-2006. Eur J Public Health 2011;21:484-90.
    Pubmed CrossRef
  67. Jung CH, Son JW, Kang S, et al. Diabetes fact sheets in Korea, 2020: an appraisal of current status. Diabetes Metab J 2021;45:1-10.
    Pubmed KoreaMed CrossRef
  68. Lee MS, Lee KS, Lee JJ, et al. Directions and current issues on the policy of prevention and management for hypertension and diabetes, and development of chronic disease prevention and management model in Korea. J Agric Med Community Health 2020;45:13-40.
  69. The 2007 Recommendations of the International Commission on Radiological Protection. ICRP publication 103. Ann ICRP 2007;37:1-332.
    Pubmed CrossRef
  70. Medical service act, Act No.17787, Enforcement Date 2021 Jun 30. Article 37 [Internet]. Korea Legislation Research Institute; 2020 [cited 2022 Sep 23]. Available from: https://elaw.klri.re.kr/kor_service/lawView.do?hseq=60889&lang=ENG
  71. Korea Disease Control and Prevention Agency. 2019 Report occupational radiation exposure in diagnostic radiology in Korea. Korea Disease Control and Prevention Agency; 2020.
  72. Korea Disease Control and Prevention Agency. 2020 Report occupational radiation exposure in diagnostic radiology in Korea. Korea Disease Control and Prevention Agency; 2021.
  73. Korea Disease Control and Prevention Agency. 2021 Report occupational radiation exposure in diagnostic radiology in Korea. Korea Disease Control and Prevention Agency; 2022.
  74. WHO coronavirus (COVID-19) dashboard [Internet]. World Health Organization; 2023 [cited 2023 Jun 26]. Available from: http://covid19.who.int/table
  75. World Health Organization. Multi-country outbreak of mpox, External Situation Report 19. World Health Organization; 2023.
  76. Korea Centers for Disease Control and Prevention. Middle East respiratory syndrome coronavirus outbreak in the Republic of Korea, 2015. Osong Public Health Res Perspect 2015;6:269-78. Erratum in: Osong Public Health Res Perspect 2016;7:138.
    Pubmed KoreaMed CrossRef
  77. Inglesby TV, O’Toole T, Henderson DA, et al. Anthrax as a biological weapon, 2002: updated recommendations for management. JAMA 2002;287:2236-52. Erratum in: JAMA 2002;288:1849.
    Pubmed CrossRef
  78. Riedel S. Plague: from natural disease to bioterrorism. Proc (Bayl Univ Med Cent) 2005;18:116-24.
    Pubmed KoreaMed CrossRef
  79. Korea Disease Control and Prevention Agency (KDCA). Guideline for gene recombinantion experiment. KDCA; 2023.
  80. Korea Disease Control and Prevention Agency (KDCA). Institutional Biosafety Committee organization & operating guide. KDCA; 2021.
  81. Whitmore A. An account of a glanders-like disease occurring in Rangoon. J Hyg (Lond) 1913;13:1-34.
    Pubmed KoreaMed CrossRef
  82. Kaestli M, Mayo M, Harrington G, et al. Landscape changes influence the occurrence of the melioidosis bacterium Burkholderia pseudomallei in soil in northern Australia. PLoS Negl Trop Dis 2009;3:e364.
    Pubmed KoreaMed CrossRef
  83. Currie BJ, Mayo M, Anstey NM, Donohoe P, Haase A, Kemp DJ. A cluster of melioidosis cases from an endemic region is clonal and is linked to the water supply using molecular typing of Burkholderia pseudomallei isolates. Am J Trop Med Hyg 2001;65:177-9.
    CrossRef
  84. Chen PS, Chen YS, Lin HH, et al. Airborne transmission of melioidosis to humans from environmental aerosols contaminated with B. pseudomallei. PLoS Negl Trop Dis 2015;9:e0003834.
    Pubmed KoreaMed CrossRef
  85. Currie BJ, Ward L, Cheng AC. The epidemiology and clinical spectrum of melioidosis: 540 cases from the 20 year Darwin prospective study. PLoS Negl Trop Dis 2010;4:e900.
    Pubmed KoreaMed CrossRef
  86. Deris ZZ, Hasan H, Siti Suraiya MN. Clinical characteristics and outcomes of bacteraemic melioidosis in a teaching hospital in a northeastern state of Malaysia: a five-year review. J Infect Dev Ctries 2010;4:430-5.
    CrossRef
  87. 2021 Multistate outbreak of melioidosis [Internet]. Centers for Disease Control and Prevention; 2021 [cited 2021 Nov 4]. Available from: https://www.cdc.gov/melioidosis/outbreak/2021/index.html
  88. Limmathurotsakul D, Wongratanacheewin S, Teerawattanasook N, et al. Increasing incidence of human melioidosis in Northeast Thailand. Am J Trop Med Hyg 2010;82:1113-7.
    Pubmed KoreaMed CrossRef
  89. Currie BJ, Jacups SP, Cheng AC, et al. Melioidosis epidemiology and risk factors from a prospective whole-population study in northern Australia. Trop Med Int Health 2004;9:1167-74.
    Pubmed CrossRef
  90. Fong SM, Wong KJ, Fukushima M, Yeo TW. Thalassemia major is a major risk factor for pediatric melioidosis in Kota Kinabalu, Sabah, Malaysia. Clin Infect Dis 2015;60:1802-7.
    CrossRef
  91. Cheng AC, Currie BJ. Melioidosis: epidemiology, pathophysiology, and management. Clin Microbiol Rev 2005;18:383-416. Erratum in: Clin Microbiol Rev 2007;20:533.
    Pubmed KoreaMed CrossRef
  92. Wiersinga WJ, Virk HS, Torres AG, et al. Melioidosis. Nat Rev Dis Primers 2018;4:17107.
    Pubmed KoreaMed CrossRef
  93. Thomas RJ. Particle size and pathogenicity in the respiratory tract. Virulence 2013;4:847-58.
    Pubmed KoreaMed CrossRef
  94. Tan GG, Liu Y, Sivalingam SP, et al. Burkholderia pseudomallei aerosol infection results in differential inflammatory responses in BALB/c and C57Bl/6 mice. J Med Microbiol 2008;57(Pt 4):508-15.
    Pubmed CrossRef
  95. Sun GW, Gan YH. Unraveling type III secretion systems in the highly versatile Burkholderia pseudomallei. Trends Microbiol 2010;18:561-8.
    Pubmed CrossRef
  96. David J, Bell RE, Clark GC. Mechanisms of disease: host-pathogen interactions between Burkholderia species and lung epithelial cells. Front Cell Infect Microbiol 2015;5:80.
    Pubmed KoreaMed CrossRef
  97. Lazar Adler NR, Govan B, Cullinane M, Harper M, Adler B, Boyce JD. The molecular and cellular basis of pathogenesis in melioidosis: how does Burkholderia pseudomallei cause disease?. FEMS Microbiol Rev 2009;33:1079-99.
    Pubmed CrossRef
  98. Nathan SA, Puthucheary SD. An electronmicroscopic study of the interaction of Burkholderia pseudomallei and human macrophages. Malays J Pathol 2005;27:3-7.
    Pubmed
  99. Ceballos-Olvera I, Sahoo M, Miller MA, Del Barrio L, Re F. Inflammasome-dependent pyroptosis and IL-18 protect against Burkholderia pseudomallei lung infection while IL-1β is deleterious. PLoS Pathog 2011;7:e1002452.
    Pubmed KoreaMed CrossRef
  100. French CT, Toesca IJ, Wu TH, et al. Dissection of the Burkholderia intracellular life cycle using a photothermal nanoblade. Proc Natl Acad Sci U S A 2011;108:12095-100.
    Pubmed KoreaMed CrossRef
  101. Newland RC. Chronic melioidosis: a case in Sydney. Pathology 1969;1:149-52.
    Pubmed CrossRef
  102. Gee JE, Gulvik CA, Elrod MG, et al. Phylogeography of Burkholderia pseudomallei isolates, Western Hemisphere. Emerg Infect Dis 2017;23:1133-8.
    Pubmed KoreaMed CrossRef
  103. Ngauy V, Lemeshev Y, Sadkowski L, Crawford G. Cutaneous melioidosis in a man who was taken as a prisoner of war by the Japanese during World War II. J Clin Microbiol 2005;43:970-2.
    CrossRef
  104. Vadivelu J, Vellasamy KM, Thimma J, et al. Survival and intra-nuclear trafficking of Burkholderia pseudomallei: strategies of evasion from immune surveillance?. PLoS Negl Trop Dis 2017;11:e0005241.
    Pubmed KoreaMed CrossRef
  105. Welkos SL, Klimko CP, Kern SJ, et al. Characterization of Burkholderia pseudomallei strains using a murine intraperitoneal infection model and in vitro macrophage assays. PLoS One 2015;10:e0124667.
    Pubmed KoreaMed CrossRef
  106. Limmathurotsakul D, Golding N, Dance DA, et al. Predicted global distribution of Burkholderia pseudomallei and burden of melioidosis. Nat Microbiol 2016;1:15008.
    Pubmed KoreaMed CrossRef
  107. Garg R, Shaw T, Vandana KE, Magazine R, Mukhopadhyay C. Melioidosis in suspected recurrent tuberculosis: a disease in disguise. J Infect Dev Ctries 2020;14:312-6.
    Pubmed CrossRef
  108. Hoffmaster AR, AuCoin D, Baccam P, et al. Melioidosis diagnostic workshop, 2013. Emerg Infect Dis 2015;21:e141045.
    Pubmed KoreaMed CrossRef
  109. Puthucheary SD. Melioidosis in Malaysia. Med J Malaysia 2009;64:266-74.
    Pubmed CrossRef
  110. Currie BJ. Melioidosis: evolving concepts in epidemiology, pathogenesis, and treatment. Semin Respir Crit Care Med 2015;36:111-25.
    Pubmed CrossRef
  111. Woods DE. Species versus biotype status. J Clin Microbiol 1999;37:3786-7.
    Pubmed KoreaMed CrossRef
  112. Podin Y, Kaestli M, McMahon N, et al. Reliability of automated biochemical identification of Burkholderia pseudomallei is regionally dependent. J Clin Microbiol 2013;51:3076-8.
    Pubmed KoreaMed CrossRef
  113. Schully KL, Young CC, Mayo M, et al. Next-generation diagnostics for melioidosis: evaluation of a prototype i-STAT cartridge to detect Burkholderia pseudomallei biomarkers. Clin Infect Dis 2019;69:421-7.
    Pubmed CrossRef
  114. Wuthiekanun V, Desakorn V, Wongsuvan G, et al. Rapid immunofluorescence microscopy for diagnosis of melioidosis. Clin Diagn Lab Immunol 2005;12:555-6.
    Pubmed KoreaMed CrossRef
  115. Phokrai P, Karoonboonyanan W, Thanapattarapairoj N, et al. A rapid immunochromatography test based on Hcp1 is a potential point-of-care test for serological diagnosis of melioidosis. J Clin Microbiol 2018;56:e00346-18.
    Pubmed KoreaMed CrossRef
  116. Lau SK, idhar S Sr, Ho CC, et al. Laboratory diagnosis of melioidosis: past, present and future. Exp Biol Med (Maywood) 2015;240:742-51.
    Pubmed KoreaMed CrossRef
  117. Chantratita N, Meumann E, Thanwisai A, et al. Loop-mediated isothermal amplification method targeting the TTS1 gene cluster for detection of Burkholderia pseudomallei and diagnosis of melioidosis. J Clin Microbiol 2008;46:568-73.
    Pubmed KoreaMed CrossRef
  118. Fairley L, Smith S, Maisrikrod S, Henning L. Systematic review and meta-analysis of diagnostic tests for diagnosis of melioidosis. Acta Trop 2021;214:105784.
    Pubmed CrossRef
  119. Wong Tzeling JM, Engku Nur Syafirah EAR, Irekeola AA, et al. One-step, multiplex, dual-function oligonucleotide of loop-mediated isothermal amplification assay for the detection of pathogenic Burkholderia pseudomallei. Anal Chim Acta 2021;1171:338682.
    Pubmed CrossRef
  120. Limmathurotsakul D, Kanoksil M, Wuthiekanun V, et al. Activities of daily living associated with acquisition of melioidosis in northeast Thailand: a matched case-control study. PLoS Negl Trop Dis 2013;7:e2072.
    Pubmed KoreaMed CrossRef
  121. Crowe A, McMahon N, Currie BJ, Baird RW. Current antimicrobial susceptibility of first-episode melioidosis Burkholderia pseudomallei isolates from the Northern Territory, Australia. Int J Antimicrob Agents 2014;44:160-2.
    Pubmed CrossRef
  122. Dance DA, Davong V, Soeng S, Phetsouvanh R, Newton PN, Turner P. Trimethoprim/sulfamethoxazole resistance in Burkholderia pseudomallei. Int J Antimicrob Agents 2014;44:368-9.
    Pubmed KoreaMed CrossRef
  123. Rhodes KA, Schweizer HP. Antibiotic resistance in Burkholderia species. Drug Resist Updat 2016;28:82-90.
    Pubmed KoreaMed CrossRef
  124. Podin Y, Sarovich DS, Price EP, et al. Burkholderia pseudomallei isolates from Sarawak, Malaysian Borneo, are predominantly susceptible to aminoglycosides and macrolides. Antimicrob Agents Chemother 2014;58:162-6.
    Pubmed KoreaMed CrossRef
  125. Chetchotisakd P, Chierakul W, Chaowagul W, et al. Trimethoprim-sulfamethoxazole versus trimethoprim-sulfamethoxazole plus doxycycline as oral eradicative treatment for melioidosis (MERTH): a multicentre, double-blind, non-inferiority, randomised controlled trial. Lancet 2014;383:807-14.
    Pubmed KoreaMed CrossRef
  126. White NJ, Dance DA, Chaowagul W, Wattanagoon Y, Wuthiekanun V, Pitakwatchara N. Halving of mortality of severe melioidosis by ceftazidime. Lancet 1989;2:697-701.
    Pubmed CrossRef
  127. Smith MD, Wuthiekanun V, Walsh AL, White NJ. In-vitro activity of carbapenem antibiotics against beta-lactam susceptible and resistant strains of Burkholderia pseudomallei. J Antimicrob Chemother 1996;37:611-5.
    Pubmed CrossRef
  128. Cheng AC, McBryde ES, Wuthiekanun V, et al. Dosing regimens of cotrimoxazole (trimethoprim-sulfamethoxazole) for melioidosis. Antimicrob Agents Chemother 2009;53:4193-9.
    Pubmed KoreaMed CrossRef
  129. Rare Disease Helpline [Internet]. Korea Disease Control and Prevention Agency; 2018 [cited 2020 Apr 13]. Available from: https://helpline.kdca.go.kr/cdchelp/
  130. Korea Disease Control and Prevention Agency. National fundholding system for rare disease. Korea Disease Control and Prevention Agency; 2022.
  131. Codjoe FS, Donkor ES. Carbapenem resistance: a review. Med Sci (Basel) 2017;6:1.
    Pubmed KoreaMed CrossRef
  132. Korea Disease Control and Prevention Agency (KDCA). 2023 Guidelines for control of healthcare-associated infection. KDCA; 2023.
  133. Joo S, Kim M, Shin E, Kim J, Yoo J. Molecular characteristic analysis and antimicrobial resistance of carbapenem-resistant Enterobacteriaceae (CRE) isolates in the Republic of Korea, 2017-2020. Public Health Wkly Rep 2021;14:3790-804.
  134. Kim MK, Joo S, Shin E, Kim J, Yoo J. Antimicrobial resistance and molecular characteristics of carbapenem-resistant Enterobacteriaceae isolated in the Republic of Korea, 2021. Public Health Wkly Rep 2023;16:541-59.
  135. Yun SJ, Kwon SM, Hur ES, et al. Outbreaks of carbapenem resistant Enterobacterales (CRE) according to the type of hospitals. Korean J healthc assoc Infect Control Prev 2022;27:162-7.
    CrossRef
  136. Centers for Disease Control and Prevention (CDC). Carbapenem-resistant Enterobacterales (CRE) [Internet]. CDC; 2019 [cited 2023 Sep 1]. Available from: https://www.cdc.gov/hai/organisms/cre/index.html
  137. Korea Disease Control and Prevention Agency (KDCA). Annual report on the notified infectious diseases in Korea, 2022. KDCA; 2023.
  138. Ahn YS, Bahk HJ, Lee Y. Epidemiology of carbapenem-resistant Enterobacteriaceae in Korea between 2018 and 2019. Public Health Wkly Rep 2021;14:413-20.
  139. Lee E, Lee S, Yoon S, Lee Y. Number of cabapenem-resistant Enterobacteriaceae infections in Republic of Korea (2018-2020). Public Health Wkly Rep 2021;14:2765-72.
  140. Jeong H, Hyun J, Lee Y. Characteristics of carbapenem-resistant Enterobacteriaceae (CRE) in the Republic of Korea, 2021. Public Health Wkly Rep 2022;15:2354-63.
  141. Centers for Disease Control and Prevention (2023). National Notifiable Diseases Surveillance System, Weekly Tables of Infectious Disease Data [Internet]. Available from: https://wonder.cdc.gov/nndss/static/2023/04/2023-04-table355.html. (cited 2023 Sep 1)
  142. Quarterly laboratory surveillance of acquired carbapenemase-producing Gram-negative bacteria in England: October 2020 to September 2022. Health Prot Rep 2023;17:1-29. Health Prot Rep 2023;17:1-29.
  143. Centers for Disease Control and Prevention (CDC). Interim guidance for a public health response to contain novel or targeted multidrug-resistant organisms (MDROs). CDC; 2022.
  144. Korea Disease Control and Prevention Agency Press Release [cited 2023 Apr 12] Available from: https://www.kdca.go.kr/board/board.es?mid=a20501010000&bid=0015&list_no=722274&cg_code=&act=view&nPage=3
  145. Holmes EC, Goldstein SA, Rasmussen AL, et al. The origins of SARS-CoV-2: a critical review. Cell 2021;184:4848-56.
    Pubmed KoreaMed CrossRef
  146. Hinshaw D, McKay B. WHO seeks to revive stalled inquiry into origins of Covid-19 with new team [Internet]. Wall Street Journal; 2021 [cited 2023 Oct 26]. Available from: https://www.wsj.com/articles/who-seeks-to-revive-stalled-inquiry-into-origins-of-covid-19-with-new-team-11632657603
  147. Cairney P, Heikkila T, Wood M. Making policy in a complex world. Cambridge University Press; 2019.
    CrossRef
  148. Shiffman J, Shawar YR. Framing and the formation of global health priorities. Lancet 2022;399:1977-90.
    Pubmed CrossRef
  149. Cairney P, Fischer M, Ingold K. Fracking in the UK and Switzerland: why differences in policymaking systems don't always produce different outputs and outcomes. Policy Polit 2018;46:125-47.
  150. World Health Organization. COVID 19 strategic preparedness and response plan - monitoring and evaluation framework. World Health Organization; 2021.
    CrossRef
  151. Korea Disease Control and Prevention AgencyNational Academy of Medicine of Korea. Analysis of the Central Disease Control Headquarters' COVID-19 pandemic response from 2020 to 2021 [Internet]. Korea Disease Control and Prevention Agency; 2023 [cited 2023 Nov 12]. Available from: https://prism.go.kr/homepage/entire/researchDetail.do?researchId=1790387-202200048&menuNo=I0000002
  152. On the 12th, the Korea Centers for Disease Control and Prevention will be promoted to the Korea Disease Control and Prevention Agency | COVID-19 Central Disaster and Safety Countermeasures Headquarters Briefing (September 8, 2020) [Internet]. KTV; 2020 [cited 2023 Nov 8]. Available from: https://www.youtube.com/watch?v=N0AEgvQ65Mc
  153. Haug N, Geyrhofer L, Londei A, et al. Ranking the effectiveness of worldwide COVID-19 government interventions. Nat Hum Behav 2020;4:1303-12.
    Pubmed CrossRef
  154. WHO warns of 'two-track pandemic' as cases decline but vaccine inequity persists [Internet]. United Nations; 2021 [cited 2023 Nov 14]. Available from: https://news.un.org/en/story/2021/06/1093472
  155. Geddes L. Different types of immunity and why they matter to COVID-19 [Internet]. VaccinesWork; 2020 [cited 2023 Nov 1]. Available from: https://www.gavi.org/vaccineswork/different-types-immunity-and-why-they-matter-covid-19?gclid=Cj0KCQjwy4KqBhD0ARIsAEbCt6jMkvzlFcbF4VV7rDqvZlGyWo_NL_em1n7lQUudfSiUSRBN3d_Y40saAnilEALw_wcB
  156. Ando H, Ikegami K, Nagata T, et al. Effect of commuting on the risk of COVID-19 and COVID-19-induced anxiety in Japan, December 2020. Arch Public Health 2021;79:222.
    Pubmed KoreaMed CrossRef
  157. Weir L. Inventing global health security, 1994-2005. In: Rushton S, Youde J, editors. Routledge handbook of global health security. London: Routledge 2014:p.18-31.
    CrossRef
  158. Tarrow S. Power in movement: social movements and contentious politics. 2nd ed. Cambridge University Press. 1998.
    CrossRef
  159. Grant W. Pressure groups, politics and democracy in Britain. 2nd ed. Harvester Wheatsheaf. 1995.
    CrossRef
  160. Snowden FM. Epidemics and society: from the Black Death to the present. Yale University Press; 2019.
    CrossRef
  161. Korea Disease Control and Prevention Agency. Guidelines for water- and foodborne disease. Korea Disease Control and Prevention Agency; 2023. p. 3-5, 43-44.
  162. World Health Organization. Foodborne disease outbreaks: guidelines for investigation and control. World Health Organization; 2008.
    CrossRef
  163. Lee J, Seo S, Noh Y, Kim H, Lee D. Results of the water- and foodborne disease surveillance during the summer of 2021. Public Health Wkly Rep 2021;14:3320-8.
  164. Kim DS, Kim I, Kim H, Shim JA, Won J, Gwak J. Results of the food and waterborne disease surveillance during the summer in 2022. Public Health Wkly Rep 2023;16:36-50.
  165. Rose JB, Epstein PR, Lipp EK, Sherman BH, Bernard SM, Patz JA. Climate variability and change in the United States: potential impacts on water- and foodborne diseases caused by microbiologic agents. Environ Health Perspect 2001;109(Suppl 2):211-21.
    Pubmed KoreaMed CrossRef
  166. Gwack J, Lee KC, Lee HJ, et al. Trends in water- and foodborne disease outbreaks in Korea, 2007-2009. Osong Public Health Res Perspect 2010;1:50-4.
    Pubmed KoreaMed CrossRef
  167. Lee SH, Yun JW, Lee JH, Jung YH, Lee DH. Trends in recent waterborne and foodborne disease outbreaks in South Korea, 2015-2019. Osong Public Health Res Perspect 2021;12:73-9.
    Pubmed KoreaMed CrossRef
  168. Korea Meteorological Administration. Climate analysis Information Monthly Newsletter - October. Korea Meteorological Administration; 2023.
  169. Shin HS, Chung KH, Yun SM, Lee S. Climate change, food-borne disease prediction, and future impact. Health Soc Welf Rev 2009;29:143-62.
    CrossRef
  170. Ministry of Food and Drug Safety. Guidelines for food safety management. Ministry of Food and Drug Safety; 2022.
  171. Liu X, He Y, Tang C, et al. Association between cold spells and childhood asthma in Hefei, an analysis based on different definitions and characteristics. Environ Res 2021;195:110738.
    Pubmed CrossRef
  172. Korea Meteorological Administration. Abnormal climate report, 2022. Korea Meteorological Administration; 2023.
  173. Lane K, Ito K, Johnson S, Gibson EA, Tang A, Matte T. Burden and risk factors for cold-related illness and death in New York City. Int J Environ Res Public Health 2018;15:632.
    Pubmed KoreaMed CrossRef
  174. Analitis A, Katsouyanni K, Biggeri A, et al. Effects of cold weather on mortality: results from 15 European cities within the PHEWE project. Am J Epidemiol 2008;168:1397-408.
    Pubmed CrossRef
  175. Korea Disease Control and Prevention Agency. The 1st climate health impact assessment report. Korea Disease Control and Prevention Agency; 2022.
    CrossRef
  176. Korea Disease Control and Prevention Agency. 2023 Guidelines for healthcare-associated infectious diseases. Korea Disease Control and Prevention Agency; 2023.
    CrossRef
  177. Tischendorf J, de Avila RA, Safdar N. Risk of infection following colonization with carbapenem-resistant Enterobactericeae: a systematic review. Am J Infect Control 2016;44:539-43.
    Pubmed KoreaMed CrossRef
  178. Lee ES, Lee SJ, Yoon SJ, Lee Y. Number of Cabapenem-resistant Enterobacteriaceae infections in Republic of Korea (2018-2020). Public Health Wkly Rep 2021;14:2765-72.
  179. Jeong HS, Hyun JH, Lee YK. Characteristics of Carbapenem-resistant Enterobacteriaceae (CRE) in the Republic of Korea, 2021. Public Health Wkly Rep 2022;15:2354-63.
  180. Public Health Agency of Canada. Tackling antimicrobial resistance and antimicrobial use: a pan-Canadian framework for action. Public Health Agency of Canada; 2017.
  181. Australian Commission on Safety and Quality in Health Care. AURA 2021: fourth Australian report on antimicrobial use and resistance in human health. Australian Commission on Safety and Quality in Health Care; 2021. p. fourth.
  182. Bijkerk P, Feenstra SG, Notermans DW, Schouls LM, Wielders CCH, Leenstra T. [Notification requirement for carbapenemase-producing Enterobacteriaceae]. Infect Bull 2020;31. Dutch. Available from: https://www.rivm.nl/weblog/meldingsplicht-voor-carbapenemaseproducerende-enterobacteriaceae-ib-09-2020
  183. Federal Government. DART 2020: fighting antibiotic resistance for the good of both humans and animals. Federal Government; 2015. p. fighting.
    CrossRef
  184. Federal Task Force on Combating Antibiotic-Resistant Bacteria. National action plan for combating antibiotic-resistant bacteria, 2020-2025. U.S. Department of Health & Human Services; 2020.
  185. Centers for Disease Control and Prevention. Facility guidance for control of Carbapenem-resistant Enterobacteriaceae (CRE): November 2015 update - CRE toolkit. Centers for Disease Control and Prevention; 2015.
  186. Minnesota Department of Health. Recommendations for the management of carbapenem-resistant Enterobacteriaceae (CRE) in acute and long-term acute care hospitals. Minnesota Department of Health; 2013.
  187. National Health Service. The management of carbapenem resistant organisms (CRO) policy. National Health Service; 2022.
    CrossRef
  188. UK Health Security Agency. Framework of actions to contain carbapenemase-producing Enterobacterales. UK Health Security Agency; 2022.
    CrossRef
  189. Schwaber MJ, Carmeli Y. The impact of a carbapenem-resistant Enterobacteriaceae outbreak on facilitating development of a national infrastructure for infection control in Israel. Clin Infect Dis 2017;65:2144-9.
    Pubmed CrossRef
  190. Ben-David D, Masarwa S, Fallach N, et al. National policy for carbapenem-resistant Enterobacteriaceae (CRE) clearance and discontinuation of contact precautions for CRE carriers in post-acute care hospitals in Israel: impact on isolation-days and new acquisitions. Clin Infect Dis 2021;72:829-35.
    Pubmed CrossRef
  191. Schwaber MJ, Lev B, Israeli A, et al. Containment of a country-wide outbreak of carbapenem-resistant Klebsiella pneumoniae in Israeli hospitals via a nationally implemented intervention. Clin Infect Dis 2011;52:848-55.
    Pubmed CrossRef
  192. Ben-David D, Masarwa S, Fallach N, et al. Success of a national intervention in controlling carbapenem-resistant Enterobacteriaceae in Israel's long-term care facilities. Clin Infect Dis 2019;68:964-71.
    Pubmed CrossRef
  193. World Health Organization. Guidelines for the prevention and control of carbapenem-resistant Enterobacteriaceae, Acinetobacter baumannii and Pseudomonas aeruginosa in health care facilities. World Health Organization; 2017.
  194. Magiorakos AP, Burns K, Rodríguez Baño J, et al. Infection prevention and control measures and tools for the prevention of entry of carbapenem-resistant Enterobacteriaceae into healthcare settings: guidance from the European Centre for Disease Prevention and Control. Antimicrob Resist Infect Control 2017;6:113.
    Pubmed KoreaMed CrossRef
  195. Yang G, Cintina I, Pariser A, Oehrlein E, Sullivan J, Kennedy A. The national economic burden of rare disease in the United States in 2019. Orphanet J Rare Dis 2022;17:163.
    Pubmed KoreaMed CrossRef
  196. Korea Disease Control and Prevention Agency. Annual report on the rare disease patients in Korea. Korea Disease Control and Prevention Agency; 2022.
    CrossRef
  197. Kang DY, Min SH, Park SK. The Korean economy: one year after the COVID-19 outbreak - an interim review of the pandemic's economic impact. Korea Institute for Industrial Economics and Trade; 2021.
    CrossRef
  198. Rafiq S, Swiston A. Mountains after mountains: Korea is containing COVID-19 and looking ahead. International Monetary Fund; 2021.
  199. Kyler J. Assessing your external environment: STEEP analysis. Competia; 2003.
  200. Proportion of elderly population aged 65 or older [Internet]. Statistics Korea; 2022 [cited 2023 Nov 22]. Available from: https://kosis.kr/statHtml/statHtml.do?orgId=101&tblId=DT_1YL20631&conn_path=I2
  201. World Health Organization. Preparedness and resilience for emerging threats (PRET) [Internet]. World Health Organization; 2023 [cited 2023 Nov 22]. Available from: https://www.who.int/initiatives/preparedness-and-resilience-for-emerging-threats
  202. Korea Disease Control and Prevention Agency. Current status and issues of chronic diseases in 2022. Korea Disease Control and Prevention Agency; 2022.
  203. Lee Y, Kim S, Hwang N, et al. 2020 The Korean elderly survey. Ministry of Health and Welfare; 2020.
  204. Statistics Korea. Annual report on the cause of death statistics. Statistics Korea; 2022.
  205. Statistics Korea. Annual report for elderly population. Statistics Korea; 2022.
    CrossRef
  206. Lee MS, Lee KS, Lee JJ, et al. Directions and current issues on the policy of prevention and management for hypertension and diabetes, and development of chronic disease prevention and management model in Korea. J Agric Med Community Health 2020;45:13-40.
  207. Korea Disease Control and Prevention Agency. Korea community health at a glance 2022: Korea Community Health Survey (KCHS). Korea Disease Control and Prevention Agency; 2023.
  208. Gyeongsangbuk-do Provincial Government. The 7th community health plan in Gyeongsangbuk-do. Gyeongsangbuk-do Provincial Government; 2019.
  209. Gyeongsangbuk-do Provincial Government. The 8th community health plan in Gyeongsangbuk-do. Gyeongsangbuk-do Provincial Government; 2023.
  210. Hyun S, Woo D, Park S. The effect of interaction between obesity and grip strength on health-related quality of life in elderly: based on the Korea National Health and Nutrition Examination Survey (2016-2018). J Health Inf Stat 2021;46:28-35.
    CrossRef
  211. Cha GH, Lim SH. Analysis of population changes and estimation of regional vitality index of small cities in non-metropolitan area. Geogr J Korea 2023;57:111-28.
    CrossRef
  212. Sejong City. The 8th (2023~2026) community health plan. Sejong City; 2023.
  213. Chungcheongnam-do. The 8th community health plan (2023~2026). Chungcheongnam-do; 2023.
  214. Chungcheongbuk-do. The 8th community health plan (2023~2026). Chungcheongbuk-do; 2023.
  215. Daejeon Metropolitan City. The 8th community health plan (2023~2026). Daejeon Metropolitan City; 2023.
  216. Lee JR. Review the change of chronic disease care in Korea. J Korean Diabetes 2022;23:251-7.
    CrossRef
  217. Kim S, Nho SJ, Kim YR, Kim J. The current status and task of non-communicable disease prevention and management of the Capital Regional Center for Disease Control and Prevention. Public Health Wkly Rep 2022;15:2835-49.
  218. National Evidence-based Healthcare Collaborating Agency. Development of Chronic Disease Management Service Model centered on primary care. National Evidence-based Healthcare Collaborating Agency; 2016.
  219. Kim HS, Yoo BN, Lee EW. Evaluation of the national chronic diseases management policy: performance and future directions. Public Health Aff 2018;2:105-20.
    CrossRef
  220. Korea Disease Control and Prevention Agency Press Release [cited 2024 Feb 5] Available from: https://daegucidcp.kr/zbbs/dn.php?tb=zbbs_report&rowid=892&num=0&dn=1
  221. Raoofi S, Pashazadeh Kan F, Rafiei S, et al. Global prevalence of nosocomial infection: a systematic review and meta-analysis. PLoS One 2023;18:e0274248.
    Pubmed KoreaMed CrossRef
  222. Korea Disease Control and Prevention Agency Press Release. 2023 [cited 2023 Nov 22]. Available from: https://www.kdca.go.kr/board/board.es?mid=a20501010000&bid=0015&list_no=722943&cg_code=&act=view&nPage=23
  223. O'Boyle C, Soule BM. Reflecting on the future of infection prevention and control: are we waiting or creating?. Am J Infect Control 2009;37:613-4.
    Pubmed KoreaMed CrossRef
  224. History of IIPW [Internet]. Association for Professionals in Infection Control and Epidemiology; 2023 [cited 2023 Nov 22]. Available from: https://infectionpreventionandyou.org/history/
  225. World Health Organization (WHO). MERS situation update, December 2022 [Internet]. WHO; 2022 [cited 2023 Nov 17]. Available from: https://applications.emro.who.int/docs/WHOEMCSR630E-eng.pdf?ua=1
  226. Korea Disease Control and Prevention Agency. MERS manual. Korea Disease Control and Prevention Agency; 2022.
  227. Cha JO, Seo YJ, Kang SK, Kim I, Gwack J. Sentinel surveillance results for influenza and acute respiratory infections during the coronavirus disease 2019 pandemic. Public Health Wkly Rep 2023;16:597-612.
  228. Choi SK, Kim JA, Lee SY, Gwack J. The results of national surveillance and response to the Middle East Respiratory Syndrome (MERS) patients under investigation (PUIs) cases in the Republic of Korea, 2019-2021. Public Health Wkly Rep 2022;15:1018-30.
    CrossRef
  229. Ryu BY, Kim EK, Shin SH, et al. Results of national surveillance and response on patients under investigation (PUIs) of Middle East respiratory syndrome coronavirus (MERS-CoV) infection in Korea, 2018. Public Health Wkly Rep 2019;12:402-9.
    CrossRef
  230. Hammond A, Laurenson-Schafer H, Marsland M, et al. Review of the 2017-2018 influenza season in the northern hemisphere. Wkly Epidemiol Rec 2018;93:429-44.
  231. Statistics Korea. Annual report on the causes of death statistics in 2019 [Internet]. Statistics Korea; 2020 [cited 2023 Oct 16]. Available from: https://kostat.go.kr/board.es?mid=a10301060100&bid=218&act=view&list_no=385219&tag=&nPage=1&ref_bid=
  232. Korea Disease Control and Prevention AgencyNational Fire Agency. 2021 Sudden cardiac arrest survey statistics. Korea Disease Control and Prevention Agency; 2022.
  233. Kim GC, Kim SY, Kim JW, et al. Variance of the COVID-19 occurrence in the community: influence on the emergency medical service and the survival of out-of-hospital cardiac arrest patients. J Korean Soc Emerg Med 2023;34:96-104.
    Pubmed KoreaMed CrossRef
  234. Shin WM, Kim JM, Park CY, Shin EH, Tchoe BH. Analysis of factors influencing the survival of patients with Out-of-Hospital of Cardiac Arrest (OHCA). Korean Public Health Res 2020;46:93-105.
  235. Ryu JH, Kim JH, Ryoo HW, et al. Out-of-hospital cardiac arrest outcomes according to the time of day: a citywide multicenter retrospective observational study. J Korean Soc Emerg Med 2022;33:28-36.
  236. Kim HS, Chun JH. Determinants on survival outcomes of sudden out-of-hospital cardiac arrest: a multilevel analysis. Korean J Emerg Med Serv 2020;24:7-26.
  237. Myat A, Song KJ, Rea T. Out-of-hospital cardiac arrest: current concepts. Lancet 2018;391:970-9.
    Pubmed CrossRef
  238. Kim SH. Factors affecting recovery of spontaneous circulation in patients before cardiac arrest in emergency department: 2012~2016 focused on medical records data. Korean Soc Law Med 2018;19:209-33.
    CrossRef
  239. Lee YK, Nho TH, Park YS, et al. Enhanced strategies through national tri-temporal analysis of public capacity prepared for laypersons' cardiopulmonary resuscitation. J Korean Soc Emerg Med 2016;27:549-55.
  240. Reynolds JC, Grunau BE, Rittenberger JC, Sawyer KN, Kurz MC, Callaway CW. Association between duration of resuscitation and favorable outcome after out-of-hospital cardiac arrest: implications for prolonging or terminating resuscitation. Circulation 2016;134:2084-94.
    Pubmed KoreaMed CrossRef
  241. Laboratory quality assurance and standardization programs [Internet]. Centers for Disease Control and Prevention; 2023 [cited 2023 Nov 8]. Available from: https://www.cdc.gov/labstandards/index.html
  242. What do CDC CSPs offer? [Internet]. Centers for Disease Control and Prevention; 2023 [cited 2023 Nov 8]. Available from: https://www.cdc.gov/labstandards/csp/csp_offerings.html
  243. UK Standards for Microbiology Investigations: quality assurance in the diagnostic infection sciences laboratory [Internet]. Public Health England; 2021 [cited 2023 Nov 8]. Available from: https://assets.publishing.service.gov.uk/media/60faa19ee90e0703bbd94a4e/Q_2i8.pdf
  244. UK Standards for Microbiology Investigations: quality assurance in the diagnostic virology and serology laboratory [Internet]. Public Health England; 2021 [cited 2023 Nov 8]. Available from: https://assets.publishing.service.gov.uk/media/60819ad18fa8f51b8f716c7c/Q_2do+.pdf
  245. Ahmad-Nejad P, Ashavaid T, Vacaflores Salinas A, et al. Current and future challenges in quality assurance in molecular diagnostics. Clin Chim Acta 2021;519:239-46.
    Pubmed CrossRef
  246. Infectious Disease Control and Prevention Act, Act No. 19419 (May 19, 2023).
  247. Park JS, Park YE, Kim GJ, Lee S. Accreditation system for national reference laboratories for infectious diseases. Public Health Wkly Rep 2019;12:1314-9.
  248. Regulations on Accreditation and Operation of National Reference Laboratory for Infectious Diseases, KDCA Act No. 97 (Apr. 28, 2022).
  249. What is Rare Disease Day? [Internet]. Rare Disease Day; 2024 [cited 2024 Jan 11]. Available from: https://www.rarediseaseday.org/what-is-rare-disease-day/
  250. Rare Disease Day 2023: our global community comes together for a more equitable world [Internet]. EURORDIS-Rare Diseases Europe; 2023 [cited 2024 Jan 11]. Available from: https://www.eurordis.org/rare-disease-day-2023-our-global-community-comes-together/
  251. Share your Colours poster [Internet]. Rare Disease Day; 2024 [cited 2024 Jan 12]. Available from: https://www.rarediseaseday.org/downloads/
  252. Korea Disease Control and Prevention Agency Press Release. 2024 [cited 2024 Jan 12]. Available from: https://www.kdca.go.kr/board/board.es?mid=a20501010000&bid=0015&list_no=722604&cg_code=&act=view&nPage=44#
  253. Korea Disease Control and Prevention Agency Press Release. 2024 [cited 2024 Jan 12]. Available from: https://www.kdca.go.kr/board/board.es?mid=a20501010000&bid=0015&list_no=723946&cg_code=&act=view&nPage=12
  254. Ministry of Health and Welfare Press Release. 2024 [cited 2024 Jan 11]. Available from: https://www.mohw.go.kr/board.es?mid=a10503010100&bid=0027&act=view&list_no=370404&tag=&nPage=156
  255. Lee JS. Genetic understanding of rare incurable diseases and considerations when reflecting health insurance policies. HIRA Policy Brief 2016;10:22-30.
  256. Ramos-Fuentes F, González-Meneses A, Ars E, Hernández-Jaras J. Genetic diagnosis of rare diseases: past and present. Adv Ther 2020;37(Suppl 2):29-37.
    Pubmed CrossRef
  257. Rehder C, Bean LJH, Bick D, et al. Next-generation sequencing for constitutional variants in the clinical laboratory, 2021 revision: a technical standard of the American College of Medical Genetics and Genomics (ACMG). Genet Med 2021;23:1399-415.
    Pubmed CrossRef
  258. Boycott KM, Vanstone MR, Bulman DE, MacKenzie AE. Rare-disease genetics in the era of next-generation sequencing: discovery to translation. Nat Rev Genet 2013;14:681-91.
    Pubmed CrossRef
  259. Korean Society of Medical Genetics and Genomics (KSMG) [Internet]. Korean Society of Medical Genetics and Genomics [cited 2023 Dec 1]. Available from: http://www.ksmg.or.kr
  260. American Board of Genetic Counseling (ABGC) [Internet]. American Board of Genetic Counseling [cited 2023 Dec 1]. Available from: https://www.abgc.net
  261. Genetic Counsellor Registration Board (GCRB) [Internet]. Genetic Counsellor Registration Board [cited 2023 Dec 1]. Available from: https://gcrb.org.uk
  262. National Society of Genetic Counselors (NSGC) [Internet]. National Society of Genetic Counselors [cited 2023 Dec 1]. Available from: https://www.nsgc.org
  263. Japanese Society for Genetic Counseling [Internet]. Japanese Society for Genetic Counseling [cited 2023 Dec 1]. Available from: http://www.jsgc.jp
  264. World Health Organization. Report on the burden of endemic health care-associated infection worldwide. World Health Organization; 2011.
    CrossRef
  265. Kim HB. Clinical and economic burden of infection with six multi-drug resistant organisms. Korea Centers for Disease Control and Prevention; 2018.
  266. World Health Organization. Global report on infection prevention and control. World Health Organization; 2022.
  267. Korea Disease Control and Prevention Agency. 2021 National Surveillance of Infection Control in healthcare facilities [Internet]. Korea Disease Control and Prevention Agency; 2022 [cited 2022 Dec 16]. Available from: https://www.kdca.go.kr/contents.es?mid=a20301080200
  268. Aghdassi SJS, Hansen S, Bischoff P, Behnke M, Gastmeier P. A national survey on the implementation of key infection prevention and control structures in German hospitals: results from 736 hospitals conducting the WHO Infection Prevention and Control Assessment Framework (IPCAF). Antimicrob Resist Infect Control 2019;8:73.
    Pubmed KoreaMed CrossRef
  269. Aghdassi SJS, Grisold A, Wechsler-Fördös A, et al. Evaluating infection prevention and control programs in Austrian acute care hospitals using the WHO Infection Prevention and Control Assessment Framework. Antimicrob Resist Infect Control 2020;9:92.
    Pubmed KoreaMed CrossRef
  270. Oppong TB, Amponsem-Boateng C, Kyere EKD, et al. Infection prevention and control preparedness level and associated determinants in 56 acute healthcare facilities in Ghana. Infect Drug Resist 2020;13:4263-71.
    Pubmed KoreaMed CrossRef
  271. Housing census [Internet]. Statistics Korea; 2005 [cited 2022 Jan 20]. Available from: https://www.k-stat.go.kr/metasvc/msda100/worddc
  272. Distribution of households by household size - EU-SILC survey [Internet]. Eurostat; 2022 [cited 2022 Jan 20]. Available from: https://ec.europa.eu/eurostat/databrowser/view/ilc_lvph03/default/table?lang=en
  273. Statistics Korea. Household Projections: 2017-2047. Statistics Korea; 2019.
  274. Jeong S, Cho SI. Effects of living alone versus with others and of housemate type on smoking, drinking, dietary habits, and physical activity among elderly people. Epidemiol Health 2017;39:e2017034.
    Pubmed KoreaMed CrossRef
  275. Widhowati SS, Chen CM, Chang LH, Lee CK, Fetzer S. Living alone, loneliness, and depressive symptoms among Indonesian older women. Health Care Women Int 2020;41:984-96.
    Pubmed CrossRef
  276. Chou KL, Ho AH, Chi I. Living alone and depression in Chinese older adults. Aging Ment Health 2006;10:583-91.
    Pubmed CrossRef
  277. Noh JW, Hong JH, Kim IH, Choi M, Kwon YD. Relationship between number of household members and prevalence of chronic diseases: a cross-sectional analysis of Korea Health Panel data. Popul Health Manag 2017;20:165.
    Pubmed CrossRef
  278. Kikuchi H, Takamiya T, Odagiri Y, et al. Gender differences in association between psychological distress and detailed living arrangements among Japanese older adults, aged 65-74 years. Soc Psychiatry Psychiatr Epidemiol 2014;49:823-30.
    Pubmed CrossRef
  279. Honjo K, Tani Y, Saito M, et al. Living alone or with others and depressive symptoms, and effect modification by residential social cohesion among older adults in Japan: the JAGES longitudinal study. J Epidemiol 2018;28:315-22.
    Pubmed KoreaMed CrossRef
  280. Oh DH, Park JH, Lee HY, Kim SA, Choi BY, Nam JH. Association between living arrangements and depressive symptoms among older women and men in South Korea. Soc Psychiatry Psychiatr Epidemiol 2015;50:133-41.
    Pubmed CrossRef
  281. Jacob L, Haro JM, Koyanagi A. Relationship between living alone and common mental disorders in the 1993, 2000 and 2007 National Psychiatric Morbidity Surveys. PLoS One 2019;14:e0215182.
    Pubmed KoreaMed CrossRef
  282. Lim LL, Kua EH. Living alone, loneliness, and psychological well-being of older persons in singapore. Curr Gerontol Geriatr Res 2011;2011:673181.
    Pubmed KoreaMed CrossRef
  283. Farrer L, Leach L, Griffiths KM, Christensen H, Jorm AF. Age differences in mental health literacy. BMC Public Health 2008;8:125.
    Pubmed KoreaMed CrossRef
  284. Kessler RC, Birnbaum HG, Shahly V, et al. Age differences in the prevalence and co-morbidity of DSM-IV major depressive episodes: results from the WHO World Mental Health Survey Initiative. Depress Anxiety 2010;27:351-64.
    Pubmed KoreaMed CrossRef
  285. Cuijpers P, Karyotaki E, Eckshtain D, et al. Psychotherapy for depression across different age groups: a systematic review and meta-analysis. JAMA Psychiatry 2020;77:694-702.
    Pubmed KoreaMed CrossRef
  286. Lin PC, Wang HH. Factors associated with depressive symptoms among older adults living alone: an analysis of sex difference. Aging Ment Health 2011;15:1038-44.
    Pubmed CrossRef
  287. Byun M. Single person household and urban policy in Seoul. Korean J Cult Soc Issues 2015;21:551-73.
    CrossRef
  288. Oshio T, Kan M. Which is riskier for mental health, living alone or not participating in any social activity? Evidence from a population-based eleven-year survey in Japan. Soc Sci Med 2019;233:57-63.
    Pubmed CrossRef
  289. Joutsenniemi K, Martelin T, Martikainen P, Pirkola S, Koskinen S. Living arrangements and mental health in Finland. J Epidemiol Community Health 2006;60:468-75.
    Pubmed KoreaMed CrossRef
  290. Steptoe A, Shankar A, Demakakos P, Wardle J. Social isolation, loneliness, and all-cause mortality in older men and women. Proc Natl Acad Sci U S A 2013;110:5797-801.
    Pubmed KoreaMed CrossRef
  291. Coyle CE, Dugan E. Social isolation, loneliness and health among older adults. J Aging Health 2012;24:1346-63.
    Pubmed CrossRef
  292. Shankar A, McMunn A, Banks J, Steptoe A. Loneliness, social isolation, and behavioral and biological health indicators in older adults. Health Psychol 2011;30:377-85.
    Pubmed CrossRef
  293. Kim AN. An empirical analysis on social exclusion in Korea. Korean J Soc Theory 2007;32:227-54.
  294. Jang YM. A study on the effects to the change of social capital from participation in elderly employment programs. Korean J Soc Welf 2011;63:261-89.
    CrossRef
  295. Spitzer RL, Kroenke K, Williams JB. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA 1999;282:1737-44.
    Pubmed CrossRef
  296. Lee S, Huh Y, Kim J, Han C. Finding optimal cut off points of the Korean version of the Patient Health Questionnaire-9(PHQ-9) for screening depressive disorders. J Korean Soc Depress Bipolar Disord 2014;12:32-6.
  297. Cornwell EY, Waite LJ. Social disconnectedness, perceived isolation, and health among older adults. J Health Soc Behav 2009;50:31-48.
    Pubmed KoreaMed CrossRef
  298. Leigh-Hunt N, Bagguley D, Bash K, et al. An overview of systematic reviews on the public health consequences of social isolation and loneliness. Public Health 2017;152:157-71.
    Pubmed CrossRef
  299. Quach LT, Burr JA. Perceived social isolation, social disconnectedness and falls: the mediating role of depression. Aging Ment Health 2021;25:1029-34.
    Pubmed KoreaMed CrossRef
  300. Robb CE, de Jager CA, Ahmadi-Abhari S, et al. Associations of social isolation with anxiety and depression during the early COVID-19 pandemic: a survey of older adults in London, UK. Front Psychiatry 2020;11:591120.
    Pubmed KoreaMed CrossRef
  301. Santini ZI, Jose PE, Cornwell EY, et al. Social disconnectedness, perceived isolation, and symptoms of depression and anxiety among older Americans (NSHAP): a longitudinal mediation analysis. Lancet Public Health 2020;5:e62-70.
    Pubmed CrossRef
  302. Teo AR. Social isolation associated with depression: a case report of hikikomori. Int J Soc Psychiatry 2013;59:339-41.
    Pubmed KoreaMed CrossRef
  303. Kang E, Lee M. Single-person households in South Korea and their policy implications. Health Welf Policy Forum 2016;234:47-56.
  304. Smith KJ, Victor C. Typologies of loneliness, living alone and social isolation, and their associations with physical and mental health. Ageing Soc 2019;39:1709-30.
    CrossRef
  305. Chan A, Malhotra C, Malhotra R, Østbye T. Living arrangements, social networks and depressive symptoms among older men and women in Singapore. Int J Geriatr Psychiatry 2011;26:630-9.
    Pubmed CrossRef
  306. Song N. An analysis on the depression of single-person household by age groups. J Humanit Soc Sci 2020;11:405-20.
    CrossRef
  307. Valtorta NK, Kanaan M, Gilbody S, Hanratty B. Loneliness, social isolation and social relationships: what are we measuring? A novel framework for classifying and comparing tools. BMJ Open 2016;6:e010799.
    Pubmed KoreaMed CrossRef
  308. Wang J, Lloyd-Evans B, Giacco D, et al. Social isolation in mental health: a conceptual and methodological review. Soc Psychiatry Psychiatr Epidemiol 2017;52:1451-61.
    Pubmed KoreaMed CrossRef
  309. Byun MR, Shin SY, Cho KJ. Single-person households, changing Seoul. Policy Rep 2009;(30):1-18.
    CrossRef
  310. Lee Y. One-person households and their policy implications. Health Welf Policy Forum 2017;252:64-77.
  311. Choi JY. A study on solitary death prevention policies [master's thesis]. Yonsei University; 2018.
  312. Shin HJ. A study on the changing current situation in lonely death and its measures in Korean society. Korean Crim Psychol Rev 2018;14:63-78.
    CrossRef
  313. Elbay RY, Kurtulmuş A, Arpacıoğlu S, Karadere E. Depression, anxiety, stress levels of physicians and associated factors in Covid-19 pandemics. Psychiatry Res 2020;290:113130.
    Pubmed KoreaMed CrossRef
  314. Sigdel A, Bista A, Bhattarai N, et al. Depression, anxiety and depression-anxiety comorbidity amid COVID-19 pandemic: an online survey conducted during lockdown in Nepal. MedRxiv [Preprint]. 2020 [cited 2021 Dec 1]. Available from: https://doi.org/10.1101/2020.04.30.20086926
    CrossRef
  315. NHS England. Social prescribing and community-based support: summary guide. NHS England; 2019.
  316. Hassan SM, Giebel C, Morasae EK, et al. Social prescribing for people with mental health needs living in disadvantaged communities: the Life Rooms model. BMC Health Serv Res 2020;20:19.
    Pubmed KoreaMed CrossRef
  317. Robertson BH, Jansen RW, Khanna B, et al. Genetic relatedness of hepatitis A virus strains recovered from different geographical regions. J Gen Virol 1992;73:1365-77.
    Pubmed CrossRef
  318. Hall E, Wodi AP, Hamborsky J, Morelli V, Schillie S. Epidemiology and prevention of vaccine-preventable diseases. 14th ed. Centers for Disease Control and Prevention. 2021.
    CrossRef
  319. Cho KY. Hepatitis A. Korean J Pediatr Gastroenterol Nutr 2010;13(Suppl 1):S70-7.
    CrossRef
  320. Kang SH, Kim MY, Baik SK. Perspectives on acute hepatitis a control in Korea. J Korean Med Sci 2019;34:e230.
    Pubmed KoreaMed CrossRef
  321. Korea Disease Control and Prevention Agency. White paper 2022. Korea Disease Control and Prevention Agency; 2023.
  322. World Health Organization. The global prevalence of hepatitis A virus infection and susceptibility: a systematic review. World Health Organization; 2010.
  323. Lee H, Cho HK, Kim JH, Kim KH. Seroepidemiology of hepatitis A in Korea: changes over the past 30 years. J Korean Med Sci 2011;26:791-6.
    Pubmed KoreaMed CrossRef
  324. Choi BY. Changing patterns of hepatitis A virus infection in Korea. . Korean J Med 2008;75 Suppl 2:S656-60.
  325. Park JH. Changes in the seroprevalence of hepatitis A virus antibody in Korea. Korean J Hepatol 2007;13:1-4.
    Pubmed CrossRef
  326. Ha J, Choi M, Yu D, Park N. Status of infectious diseases reporting in 2022. Public Health Wkly Rep 2023;16:1275-85.
  327. Chung J, Seo S, Park E, Cho S, Lee M, Gwack J. Surveillance and epidemiological characteristics of hepatitis E in the Republic of Korea. Public Health Wkly Rep 2023;16:1-15.
  328. Statistics Korea. Cause of deaths statistics in 2022. Statistics Korea; 2023.
  329. Micro Data Integrated Service (MDIS) [Internet]. Statistics Korea; 2023 [cited 2023 Oct 23]. Available from: https://mdis.kostat.go.kr/
  330. Korean Statistical Information Service (KOSIS) [Internet]. Statistics Korea; 2023 [cited 2023 Oct 23]. Available from: https://kosis.kr
  331. Korea Disease Control and Prevention Agency. The Third National Strategic Plan for TB Control in Republic of Korea, 2023~2027 [Internet]. Korea Disease Control and Prevention Agency; 2023 [cited 2023 Oct 23]. Available from: https://www.kdca.go.kr/gallery.es?mid=a20503010000&bid=0002&act=view&list_no=146078
  332. Korea Disease Control and Prevention Agency. Annual report on the notified tuberculosis in Korea, 2022. Korea Disease Control and Prevention Agency; 2023.
    CrossRef
  333. World Health Organization. Global tuberculosis report 2023 [Internet]. World Health Organization; 2023 [cited 2023 Nov 30]. Available from: https://www.who.int/teams/global-tuberculosis-programme/tb-reports/global-tuberculosis-report-2023
  334. United Nations. Political declaration of the high-level meeting of the General Assembly on the fight against tuberculosis: resolution [Internet]. United Nations; 2018 [cited 2023 Nov 30]. Available from: https://digitallibrary.un.org/record/1649568?ln=en
  335. United Nations. Political declaration of the high-level meeting on the fight against tuberculosis: resolution [Internet]. United Nations; 2023 [cited 2023 Nov 30]. Available from: https://digitallibrary.un.org/record/4025280?ln=en
  336. World Health Organization. Tuberculosis data [Internet]. World Health Organization; 2023 [cited 2023 Nov 30]. Available from: https://www.who.int/teams/global-tuberculosis-programme/data
  337. Korea Disease Control and Prevention Agency Press Release [cited 2023 Nov 30] Available from: https://www.kdca.go.kr/board/board.es?mid=a20501010000&bid=0015&list_no=723534&cg_code=&act=view&nPage=1
  338. World Health Organization (WHO). Influenza laboratory surveillance information: virus detections by subtype reported to FluNet [Internet]. World Health Organization; 2023 [cited 2023 Dec 11]. Available from: https://app.powerbi.com/view?r=eyJrIjoiZTkyODcyOTEtZjA5YS00ZmI0LWFkZGUtODIxNGI5OTE3YjM0IiwidCI6ImY2MTBjMGI3LWJkMjQtNGIzOS04MTBiLTNkYzI4MGFmYjU5MCIsImMiOjh9
  339. Kim HM, Lee NJ, Kim MS, Kang C, Chung YS. Detection of neuraminidase inhibitors-resistant influenza virus through genetic and phenotypic analysis in Korea. Public Health Wkly Rep 2019;12:410-5.
  340. Lee NJ, Woo SH, Lee JH, Rhee JE, Kim EJ. 2021-2022 Influenza and respiratory viruses laboratory surveillance report in the Republic of Korea. Public Health Wkly Rep 2023;16:53-65.
  341. Ben Moussa M, Buckrell S, Rahal A, et al. National influenza mid-season report, 2022-2023: a rapid and early epidemic onset. Can Commun Dis Rep 2023;49:10-4.
    Pubmed KoreaMed CrossRef
  342. World Health Organization (WHO). Recommended composition of influenza virus vaccines for use in the 2023-2024 northern hemisphere influenza season. World Health Organization; 2023.
  343. Kim HM, Rhee JE, Lee NJ, et al. Recent increase in the detection of human parainfluenza virus during the coronavirus disease-2019 pandemic in the Republic of Korea. Virol J 2022;19:215.
    Pubmed KoreaMed CrossRef
  344. Olsen SJ, Winn AK, Budd AP, et al. Changes in influenza and other respiratory virus activity during the COVID-19 pandemic - United States, 2020-2021. MMWR Morb Mortal Wkly Rep 2021;70:1013-9.
    Pubmed KoreaMed CrossRef
  345. Limb M. RSV: the year the respiratory infection "took its gloves off". BMJ 2021;374:n2078.
    Pubmed CrossRef
  346. Eden JS, Sikazwe C, Xie R, et al. Off-season RSV epidemics in Australia after easing of COVID-19 restrictions. Nat Commun 2022;13:2884.
    Pubmed KoreaMed CrossRef
  347. Chow EJ, Uyeki TM, Chu HY. The effects of the COVID-19 pandemic on community respiratory virus activity. Nat Rev Microbiol 2023;21:195-210.
    Pubmed KoreaMed CrossRef

Share

  • line

PHWR